Colorectal cancer, excluding all cancers (controls excluding all cancers)

C3_COLORECTAL_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_COLON_EXALLC C3_RECTOSIGMOID_JUNCTION_EXALLC C3_RECTUM_EXALLC	12187
6. Filter based on genotype QC (FinnGen only)	12187

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_COLORECTAL_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_COLON_EXALLC\|C3_RECTOSIGMOID_JUNCTION_EXALLC\|C3_RECTUM_EXALLC
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Colorectal cancer, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12187	5223	6964
Unadjusted period prevalence (%)	2.52	1.78	3.07
Median age at first event (years)	68.55	67.19	69.57

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9123: Matched controls
90306

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

7363.7

323.0

699

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.4

323.0

1654

4289

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

323.0

333

WX302

NOMESCO Finland

Thoracal epidural anesthesy

41.9

323.0

2277

711

A04AA55

ATC

palonosetron, combinations; systemic

+∞

323.0

340

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

360

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

13.1

323.0

1815

1673

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

323.0

423

UJF32

NOMESCO Finland

Coloscopy

10.7

323.0

6142

14569

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

323.0

392

H02AB02

ATC

dexamethasone; systemic

88.1

323.0

2354

355

WF002

NOMESCO Finland

Radical radiotherapy

98.7

323.0

464

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

323.0

767

L01BC06

ATC

capecitabine; oral

+∞

323.0

3435

C61

ICD-10 Finland

Malignant neoplasm of prostate

229.0

323.0

764

JN4BD

NOMESCO Finland

Extensive body CT

22.3

323.0

3161

2094

ZX090

NOMESCO Finland

Other technic of radiotherapy

302.9

323.0

351

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

9.2

323.0

888

1045

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

323.0

654

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

323.0

683

ZX120

NOMESCO Finland

Intravenous

4.5

323.0

1267

3097

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

10603.1

323.0

1761

Z93.3

ICD-10 Finland

Colostomy status

88.3

323.0

553

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

28.3

323.0

810

309

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

129.3

323.0

483

N02AA05

ATC

oxycodone; systemic

3.9

323.0

2001

6063

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

323.0

320

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

323.0

1032

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

12.1

323.0

808

716

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4495.0

323.0

1220

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

323.0

1670

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

1848.9

323.0

507

JN4AD

NOMESCO Finland

Body CT examination

16.6

323.0

1850

1359

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

14850.4

323.0

1301

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

4447

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

323.0

818

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

323.0

315

A04AA02

ATC

granisetron; systemic, transdermal

1127.7

323.0

2110

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

8214.3

323.0

772

A04AD12

ATC

aprepitant; systemic

1672.7

323.0

316

D75

ICPC

Malignant neoplasm colon/rectum

513.1

323.0

676

116

Kela drug reimbursment

Prostate cancer

+∞

323.0

419

JG1BG

NOMESCO Finland

MRI of rectum

401.6

323.0

611

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

104.3

323.0

719

A03FA01

ATC

metoclopramide; systemic, rectal

14.7

323.0

4285

5121

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

194.1

323.0

656

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

323.0

440

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

7839.6

323.0

740

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1271.2

323.0

925

WZC30

NOMESCO Finland

Teaching

6.9

323.0

2289

4158

WX402

NOMESCO Finland

General anaesthesia

3.8

323.0

1819

5535

JFB30

NOMESCO Finland

Right hemicolectomy

90.4

323.0

1219

154

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

971.1

323.0

377

TPH07

NOMESCO Finland

Cathetrisation of artery

5.3

323.0

1956

4436

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

323.0

488

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

323.0

598

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.3

323.0

1084

2236

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

30.4

323.0

1335

507

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.1

323.0

675

591

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

323.0

908

WF049

NOMESCO Finland

Radiotherapy of metastasis

703.1

323.0

473

B01AB05

ATC

enoxaparin; parenteral

5.1

323.0

4832

16192

WX408

NOMESCO Finland

General anesthesy, balanced

4.4

323.0

3711

12271

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

323.0

348

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

181.8

323.0

1114

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

211.6

323.0

871

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

323.0

1427

JFF23

NOMESCO Finland

Transversostomy

127.1

323.0

851

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

323.0

543

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

323.0

363

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

4.1

323.0

3716

12844

Z51.5

ICD-10 Finland

Palliative care

13.7

323.0

1126

916

ZX070

NOMESCO Finland

Intensity modified radiotherapy

821.3

323.0

321

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

323.0

2886

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

323.0

409

JG1CG

NOMESCO Finland

Extensive MRI of rectum

251.6

323.0

482

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

43.9

323.0

527

126

WF001

NOMESCO Finland

Preoperative radiotherapy

9043.9

323.0

842

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

936

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1686.0

323.0

903

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

323.0

663

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

3093.8

323.0

606

B01AB10

ATC

tinzaparin; parenteral

8.0

323.0

1231

1725

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

68.7

323.0

399

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

323.0

3160

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

323.0

527

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

600.2

323.0

517

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1474.2

323.0

1497

XX3DW

NOMESCO Finland

Time consuming IT work

8.1

323.0

1310

1825

TJF80

NOMESCO Finland

Ostomy education

86.6

323.0

566

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

6093.5

323.0

1108

A04AA01

ATC

ondansetron; systemic, rectal

15.6

323.0

931

654

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

13.3

323.0

2995

3205

JN4CD

NOMESCO Finland

Very extensive body CT

17.6

323.0

922

572

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

699.3

323.0

953

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

3835.0

323.0

382

115

Kela drug reimbursment

Breast cancer

+∞

322.5

309

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

641.5

317.6

314

JFB46

NOMESCO Finland

Resection of sigmoid colon

19.4

311.6

487

262

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

311.0

298

UJG02

NOMESCO Finland

Proctoscopy

10.7

308.6

623

612

WX600

NOMESCO Finland

Single shot through catheter

33.9

306.7

407

124

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

303.6

291

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

500.4

296.1

295

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

295.2

283

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

1478.0

292.8

285

L03AA13

ATC

pegfilgrastim; parenteral

1478.0

292.8

285

PJA12

NOMESCO Finland

Sentinel node biopsy

329.6

289.4

293

JFF10

NOMESCO Finland

Loop enterostomy

71.9

286.1

330

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

7.6

285.7

711

995

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

17.7

283.8

458

269

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

283.7

272

JFB43

NOMESCO Finland

Left hemicolectomy

40.9

281.4

358

WF003

NOMESCO Finland

Adjuvant radiotherapy

198.2

279.2

291

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

132.9

278.1

299

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

277.4

266

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

5.8

266.9

816

1507

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

265.9

255

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

56.9

265.2

317

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1313.0

264.6

258

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

531.6

263.4

262

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

262.7

252

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.9

261.9

940

2084

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

79.2

258.2

294

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

10.4

256.8

525

JN3AD

NOMESCO Finland

Abdominal CT examination

4.1

254.4

1084

2846

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

1233.7

248.9

243

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

135.5

247.8

266

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

247.0

237

WF004

NOMESCO Finland

Palliative radiotherapy

498.0

246.7

246

ZXC96

NOMESCO Finland

Robot assisted procedure

25.8

245.0

349

139

ZX095

NOMESCO Finland

Combined chemoradiotherapy

2264.2

240.5

233

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

239.7

230

JAH00

NOMESCO Finland

Laparotomy

7.8

237.3

577

775

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

231.3

222

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

231.3

222

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

226.4

2281

10807

L02AE02

ATC

leuprorelin; implant, parenteral

44.9

226.1

282

L01BC59

ATC

trifluridine, combinations; systemic

+∞

226.1

217

L03AA02

ATC

filgrastim; parenteral

75.5

226.0

259

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

46.9

223.1

276

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2078.2

221.7

215

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2047.3

218.6

212

WW500

NOMESCO Finland

Blood transfusion

7.5

218.0

544

758

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

217.7

209

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

214.6

206

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

273.2

210.2

215

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

171.5

208.9

220

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

208.3

200

A79

ICPC

Malignancy NOS

125.6

206.3

223

N02BE01

ATC

paracetamol; systemic, rectal

2.3

204.0

7764

63978

369

Kela drug reimbursment

Regorafenib

+∞

203.1

195

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

201.0

193

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

13.2

200.7

364

283

176

Kela drug reimbursment

Regorafenib

+∞

196.8

189

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

195.7

188

1XC07

NOMESCO Finland

+∞

190.5

183

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4.6

189.8

710

1624

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

188.4

181

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

197.1

187.0

195

JFB00

NOMESCO Finland

Partial resection of small intestine

10.3

186.0

382

383

SPAT1125

SPAT

Stoma care and guidance

8.7

184.3

415

490

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

183.2

176

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

183.2

176

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

24.6

181.0

261

108

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

178.0

171

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

175.9

169

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

436.3

173.7

174

JJB10

NOMESCO Finland

Atypcal resection of liver

576.2

173.2

172

L02BB03

ATC

bicalutamide; oral

+∞

172.8

166

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.2

172.3

1003

3341

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

171.7

165

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

169.6

163

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

169.0

1701

7892

Y77

ICPC

Malignant neoplasm prostate

177.5

167.6

176

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

7.7

166.2

403

535

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

164.4

158

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

545.3

163.9

163

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

163.4

157

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.2

163.3

675

1695

L02BG04

ATC

letrozole; oral

36.2

161.9

211

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.8

161.1

1149

4377

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

159.2

1081

3989

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.2

156.5

519

1039

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.4

155.6

431

692

ZX080

NOMESCO Finland

Image guided radiotherapy

514.5

154.5

154

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

148.3

4091

28116

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

54.4

148.0

178

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1462.1

146.6

143

K56.7

ICD-10 Finland

Ileus, unspecified

7.4

146.0

366

510

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.6

145.5

706

2034

JAL30

NOMESCO Finland

Omentectomy

34.7

143.7

189

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

143.3

1305

5701

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

706.8

142.7

141

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

142.5

137

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

142.4

1223

5172

Z51.0

ICD-10 Finland

Radiotherapy session

356.6

141.6

143

JAH01

NOMESCO Finland

Laparoscopy

5.1

140.4

474

966

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

140.4

135

R4110

NOMESCO Finland

Physiotherapy

2.0

140.3

2409

13970

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.2

140.2

572

1414

Z93

ICD-10 Finland

Artificial opening status

67.9

139.6

162

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.3

139.4

756

2375

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

63.1

138.9

163

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

72.9

138.3

159

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

137.3

132

HAC20

NOMESCO Finland

Total mastectomy

132.5

134.9

145

A02BC02

ATC

pantoprazole; systemic

1.7

134.0

5676

43954

E0000UV

ATC

1.8

130.7

3316

21901

L01XE21

ATC

[U] regorafenib; oral

+∞

130.0

125

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.7

128.5

344

526

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.4

126.9

494

1166

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

217.4

125.5

130

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

19.6

124.2

192

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.9

122.2

542

1442

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

47.1

121.7

150

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

121.6

117

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

395.1

118.4

119

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

117.5

113

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

68.2

117.3

136

Z31.5

ICD-10 Finland

Genetic counselling

5.4

117.3

373

709

WX704

NOMESCO Finland

Intubation

3.0

117.2

741

2585

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

12.2

116.8

218

180

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

1140.9

116.5

114

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

116.4

112

B01AB04

ATC

dalteparin; parenteral

3.4

116.3

620

1915

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

1130.8

115.5

113

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

114.3

110

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.8

113.6

399

847

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

112.1

819

3130

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

111.2

107

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

6.6

110.3

296

454

Z43.3

ICD-10 Finland

Attention to colostomy

70.6

110.2

127

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

15.7

108.7

182

117

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

108.1

104

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

108.1

104

HAB40

NOMESCO Finland

Wedge excision of mammary gland

17.0

107.7

175

104

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

6.1

107.2

308

517

JGB36

NOMESCO Finland

Wide excision of rectum

+∞

107.0

103

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

107.0

103

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

220.2

106.4

110

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

105.9

2835

18720

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.7

105.8

256

338

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

9.0

105.6

231

259

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

14.8

104.4

179

122

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

13.0

104.1

189

147

V03AF03

ATC

calcium folinate; systemic

1009.2

103.0

101

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

78.3

102.9

117

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

102.9

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

32.0

102.4

137

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

101.8

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

22.7

101.4

149

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

100.8

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

100.8

JFB50

NOMESCO Finland

Other resection of colon

33.4

100.5

133

JF2AB

NOMESCO Finland

Colongraphy with X-ray

35.5

100.4

131

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

100.0

1156

5601

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.1

99.9

412

1024

NK6AN

NOMESCO Finland

Total body bone isotope imaging

20.9

99.5

150

S18

ICPC

Laceration/cut

1.6

97.8

3546

25349

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

958.6

97.8

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

24.2

97.2

140

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.3

97.1

242

334

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

96.6

R4190

NOMESCO Finland

Nutritional therapy

5.4

95.5

299

558

L02BA01

ATC

tamoxifen; oral

62.3

95.5

112

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

244.9

95.4

D77

ICPC

Malignant digestive neopl other/NOS

198.0

95.1

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.3

94.7

374

892

C50.99

ICD-10 Finland

Breast, unspecified

928.3

94.7

SPAT1262

SPAT

Handing over of treatment supplies

1.8

94.6

1858

11049

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.4

94.1

298

563

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

165.0

93.9

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

462.6

93.1

L01BC53

ATC

tegafur, combinations; systemic

+∞

92.5

HA1AA

NOMESCO Finland

X-ray mammography

4.4

92.0

349

801

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

91.4

SPAT1153

SPAT

Removal of sutures

1.7

91.1

2738

18508

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

79.4

90.8

103

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

89.7

560

1927

D70.82

ICD-10 Finland

Drug-induced neutropenia

18.6

88.7

139

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

88.3

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

33.9

87.3

115

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

87.3

D99

ICPC

Disease digestive system other

8.1

86.8

202

251

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

5.3

86.7

278

533

D18

ICPC

Change in faeces/bowel movements

4.8

86.5

305

649

TQW40

NOMESCO Finland

Remowal of suture of skin

2.7

86.5

650

2513

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

85.2

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

103.3

84.6

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

5.1

84.5

280

557

L03AA14

ATC

lipegfilgrastim; parenteral

827.3

84.3

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

22.8

84.0

123

ZZR00

NOMESCO Finland

Flap of skin

10.8

83.9

166

155

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.2

83.9

341

836

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

34.4

83.8

110

R50.9

ICD-10 Finland

Fever, unspecified

2.0

83.6

1144

5926

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

83.1

KCD02

NOMESCO Finland

Transurethral resection of bladder

12.6

83.0

152

121

Z93.2

ICD-10 Finland

Ileostomy status

24.3

82.9

119

UJF34

NOMESCO Finland

Left colonoscopy

10.6

82.6

165

157

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

82.3

1556

9079

Z43.2

ICD-10 Finland

Attention to ileostomy

50.0

82.3

100

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

807.1

82.3

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

807.1

82.3

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

82.1

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

82.1

JFB40

NOMESCO Finland

Resection of transverse colon

40.1

82.0

104

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

+∞

81.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.7

80.9

214

322

A06AH03

ATC

naloxegol; oral

16.1

80.0

132

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

80.0

K92.1

ICD-10 Finland

Melaena

2.6

79.8

639

2559

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

28.7

79.5

109

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.3

78.6

427

1331

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

77.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

77.8

2547

17453

WX110

NOMESCO Finland

Local anesthesy

1.5

77.8

5059

40750

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

106.1

77.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

77.3

588

2287

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

76.9

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.9

76.4

509

1826

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

+∞

75.8

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

75.8

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

11.1

75.5

147

133

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

74.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

74.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

74.8

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

157.6

74.8

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

157.6

74.8

JKA20

NOMESCO Finland

Cholecystectomy

3.4

74.2

382

1143

TPX15

NOMESCO Finland

Removal of vascular injection port

22.8

73.2

107

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

+∞

72.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

72.7

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

72.7

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.4

72.6

278

644

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

+∞

71.7

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

149.6

70.7

JJB30

NOMESCO Finland

Excision of two segments of liver

351.3

70.4

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.9

69.7

463

1654

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

69.6

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

346.2

69.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.9

69.1

304

800

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

94.8

68.6

J01MA12

ATC

levofloxacin; systemic

1.7

68.6

1624

10114

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

46.6

68.3

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

341.2

68.3

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

65.6

68.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

232.6

68.0

JEA00

NOMESCO Finland

Appendectomy

2.7

67.7

508

1956

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

66.5

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

28.4

66.3

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.3

65.7

352

1085

JFB20

NOMESCO Finland

Ileocaecal resection

14.7

65.7

112

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

65.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.1

65.3

184

302

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

+∞

64.4

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

46.3

64.3

JFF26

NOMESCO Finland

Sigmoidostomy

38.5

63.5

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

62.3

C50

ICD-10 Finland

Malignant neoplasm of breast

131.5

61.6

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

6.7

61.5

162

243

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

7.7

61.4

147

192

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

595.8

60.6

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

60.2

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

+∞

60.2

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

60.2

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

46.1

60.2

128

Kela drug reimbursment

Cancers of female genital organs

585.7

59.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

59.4

674

3200

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

58.1

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

+∞

58.1

6434

FHL

Anterior resection

29.2

58.1

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

199.1

57.8

XX1AD

NOMESCO Finland

Other CT-examination

73.2

57.8

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

57.1

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

57.1

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

57.1

6404

FHL

Hemicolectomy on the right

27.8

56.6

JFF24

NOMESCO Finland

Laparoscopic transversostomy

102.9

56.6

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

14.5

56.6

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

555.6

56.4

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

56.2

651

3119

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

56.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

55.7

686

3373

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

146.8

55.7

WX002

NOMESCO Finland

Sedation and analgesia

1.6

55.3

1662

10978

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

11.0

55.1

107

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

55.0

UKC02

NOMESCO Finland

Cystoscopy

1.7

54.9

1408

8911

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

54.0

L02BX02

ATC

degarelix; parenteral

+∞

54.0

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

54.0

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.0

54.0

180

362

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

68.5

53.9

ZX121

NOMESCO Finland

Central venous catheter

24.0

53.7

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

53.7

420

1655

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

85.4

53.6

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.6

53.1

118

137

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

19.7

53.1

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

46.2

53.0

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

269.7

53.0

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.1

52.1

212

521

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

+∞

50.9

JFF13

NOMESCO Finland

Terminal enterostomy

17.2

50.7

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

16.8

50.3

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.4

50.1

254

752

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

8.7

50.0

110

126

KCC10

NOMESCO Finland

Cystoprostatectomy

172.4

49.7

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

12.9

49.5

K65.0

ICD-10 Finland

Acute peritonitis

5.0

49.4

165

333

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

14.1

49.2

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

48.8

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.5

48.1

177

395

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.5

48.0

P01AB01

ATC

metronidazole; oral, rectal

1.4

48.0

2835

21627

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

22.5

48.0

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

243.7

47.8

1XC08

NOMESCO Finland

+∞

47.8

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

47.8

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

47.8

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.0

47.5

200

508

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

51.6

47.4

N02AX02

ATC

tramadol; systemic, rectal

1.4

46.8

3381

26735

ZX050

NOMESCO Finland

Stereotactic radiotherapy

23.8

46.8

8480/3-C18.4

ICD-O-3

Mucinous adenocarcinoma of transverse colon

+∞

46.7

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

46.7

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.0

46.7

132

219

JFC10

NOMESCO Finland

Ileotransversostomy

124.3

46.6

X76

ICPC

Malignant neoplasm breast female

101.5

46.6

J01MA02

ATC

ciprofloxacin; systemic

1.4

46.4

3161

24723

KC1GB

NOMESCO Finland

Cystography with X-ray

20.8

46.2

WX882

NOMESCO Finland

High dependency care

3.0

46.2

277

925

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

455.3

46.1

R18

ICD-10 Finland

Ascites

4.3

46.0

175

404

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

+∞

45.7

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

45.7

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

16.4

45.6

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.6

45.1

209

576

ZX112

NOMESCO Finland

Subcutaneous

6.3

45.1

123

195

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

17.1

45.0

JMA10

NOMESCO Finland

Transabdominal total splenectomy

13.9

44.9

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

44.6

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

44.6

8140/3-C18.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of colon

+∞

44.6

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

5.2

44.6

143

276

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

44.2

761

4242

JFA42

NOMESCO Finland

Endoscopic injection in colon

10.7

43.9

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.6

43.6

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

43.6

8480/3-C18.9

ICD-O-3

Mucinous adenocarcinoma of colon, NOS

+∞

43.6

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

95.5

43.6

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.7

43.5

153

327

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

24.3

42.9

6435

FHL

Abdominoperineal resection and colostomy

93.5

42.6

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

42.6

E34.0

ICD-10 Finland

Carcinoid syndrome

114.3

42.6

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

15.0

42.3

R11

ICD-10 Finland

Nausea and vomiting

1.9

42.1

616

3235

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.7

42.0

110

165

L02BG03

ATC

anastrozole; oral

43.1

42.0

XKD00

NOMESCO Finland

Uroflowmetry

1.6

41.9

1329

8832

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

213.7

41.7

SPAT1109

SPAT

Analgesia with portable analgesic pump

10.1

41.6

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

41.5

K56.0

ICD-10 Finland

Paralytic ileus

4.7

41.5

144

304

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

7.8

41.3

124

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.5

41.1

327

1299

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

28.8

40.5

D16

ICPC

Rectal bleeding

3.3

40.5

213

649

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

+∞

40.5

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

18.2

39.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

39.7

2000

14684

A06AD11

ATC

lactulose; oral

1.6

39.7

1333

8966

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

106.9

39.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

39.4

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

39.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

38.9

633

3452

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

385.1

38.9

N03AX16

ATC

pregabalin; oral

1.5

38.7

1775

12783

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

198.7

38.7

LCD00

NOMESCO Finland

Hysterectomy

2.6

38.6

302

1191

1533A

ICD-9 Finland

Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]

+∞

38.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

38.4

1534A

ICD-9 Finland

Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]

+∞

38.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

38.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

38.3

1286

8647

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.7

38.1

171

460

JFF30

NOMESCO Finland

Other colostomy

29.8

38.0

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.9

37.9

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

62.4

37.9

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

14.1

37.8

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

12.3

37.8

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.5

37.6

114

207

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

101.9

37.5

G04BE03

ATC

sildenafil; oral

7.8

37.5

113

C18.52

ICD-10 Finland

Malignant tumor of flexura lienalis carcinoma of adenoma

+∞

37.4

C209

ICD-10 Finland

+∞

37.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

37.4

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

39.0

37.2

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.8

37.2

TJG20

NOMESCO Finland

Transanal irrigation

17.3

37.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.3

37.0

350

1525

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

61.0

36.9

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

36.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

36.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

36.3

8070/3-C20.9

ICD-O-3

Squamous cell carcinoma, NOS, of rectum, NOS

+∞

36.3

L01BC04

ATC

carmofur; oral

+∞

36.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

36.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

355.0

35.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.2

35.5

192

599

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

35.3

1030

6679

8000/3-C20.9

ICD-O-3

Neoplasm, malignant of rectum, NOS

+∞

35.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

35.3

SPAT1131

SPAT

Colonoscopy

2.4

35.1

305

1272

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

8.6

35.1

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

12.5

34.9

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

66.1

34.8

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

77.6

34.6

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

122.5

34.5

JN4DD

NOMESCO Finland

Scout CT scan of torso

46.3

34.5

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

10.4

34.4

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

34.4

532

2847

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

34.2

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

34.2

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

34.2

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

34.2

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.9

34.0

215

746

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

4.2

33.7

131

311

JJA20

NOMESCO Finland

Open biopsy of liver

17.0

33.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

33.2

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

9.4

33.1

JN6AD

NOMESCO Finland

CT of torso and neck

8.0

33.0

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

324.9

32.8

WX892

NOMESCO Finland

Monitored bed care

1.8

32.6

624

3587

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

44.1

32.6

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

32.2

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

32.2

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

27.3

32.1

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

14.0

32.1

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

10.5

32.0

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

18.7

31.9

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

39.7

31.9

3AC01

NOMESCO Finland

4.3

31.5

119

275

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

31.1

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

31.1

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

31.1

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

31.1

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.2

31.1

122

293

KCD10

NOMESCO Finland

Partial cystectomy

38.8

31.0

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

30.8

259

1061

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.0

30.7

126

315

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.1

30.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

30.6

450

2363

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

30.5

289

1258

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

30.3

250

1017

8480/3-C18.3

ICD-O-3

Mucinous adenocarcinoma of hepatic flexure of colon

+∞

30.1

L02BB04

ATC

enzalutamide; oral

+∞

30.1

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

30.1

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

30.1

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

30.1

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

24.5

29.8

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

20.8

29.7

JFH10

NOMESCO Finland

Total colectomy and ileostomy

13.3

29.7

ZX100

NOMESCO Finland

Oral

3.7

29.2

131

354

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

29.8

29.2

JAQ10

NOMESCO Finland

Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity

+∞

29.1

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

29.1

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

29.1

L01EX05

ATC

regorafenib; oral

+∞

29.1

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

+∞

29.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

29.0

557

3205

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

9.1

28.8

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.6

28.7

135

380

S77

ICPC

Malignant neoplasm of skin

15.6

28.7

D01.0

ICD-10 Finland

Carcinoma in situ: Colon

102.6

28.5

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

11.5

28.3

G04CA02

ATC

tamsulosin; oral

1.3

28.2

2210

17352

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

28.2

305

1415

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

28.2

1134

7895

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

12.7

28.1

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

28.0

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

28.0

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

28.0

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

8.8

27.8

GDC00

NOMESCO Finland

Lobectomy of lung

16.0

27.8

B80

ICPC

Iron deficiency anaemia

2.9

27.7

171

584

JAD10

NOMESCO Finland

Repair of incisional hernia

4.6

27.7

213

Z71.8

ICD-10 Finland

Other specified counselling

1.4

27.6

1489

10980

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

99.3

27.5

JFC20

NOMESCO Finland

Other enterocolostomy

46.8

27.3

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

27.2

183

663

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

52.9

27.0

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

27.0

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

27.0

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

27.0

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

27.0

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

27.0

8000/3-C18.9

ICD-O-3

Neoplasm, malignant of colon, NOS

+∞

27.0

L57.0

ICD-10 Finland

Actinic keratosis

1.7

26.8

611

3702

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

26.7

498

2840

D48.42

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum originating in the appendix

269.0

26.6

K62.7

ICD-10 Finland

Radiation proctitis

269.0

26.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

26.5

807

5272

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

96.0

26.5

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.2

26.5

142

443

XQ902

NOMESCO Finland

Other photography

6.4

26.3

109

GDB10

NOMESCO Finland

Wedge resection of lung

20.4

26.3

ZXC40

NOMESCO Finland

Use of ultrasound

6.8

26.1

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

36.4

26.0

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

25.9

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

25.9

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

25.9

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

25.9

J01DB01

ATC

cefalexin; oral

1.3

25.9

6252

56796

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

21.0

25.8

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

59.5

25.8

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

11.1

25.8

TQW20

NOMESCO Finland

Tatoe

30.7

25.7

H01CB03

ATC

lanreotide; parenteral

39.7

25.6

QX9VV

NOMESCO Finland

258.6

25.6

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

92.7

25.5

KA1FN

NOMESCO Finland

Isotope renography

7.0

25.5

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

8.7

25.4

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

49.6

25.1

WGA11

NOMESCO Finland

Planning of pain management

18.9

25.0

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

+∞

24.9

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

24.9

8480/3-C19.9

ICD-O-3

Mucinous adenocarcinoma of rectosigmoid junction

+∞

24.9

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

24.9

LEC00

NOMESCO Finland

Partial excision of vagina

29.8

24.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

24.7

268

1248

KFC10

NOMESCO Finland

Bilateral orchiectomy

69.3

24.7

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

248.2

24.6

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

89.4

24.5

C90.0

ICD-10 Finland

Multiple myeloma

89.4

24.5

L02AE04

ATC

triptorelin; parenteral

31.8

24.4

KAC10

NOMESCO Finland

Total nephrectomy with capsule

15.3

24.4

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

55.5

23.9

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

23.9

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

23.9

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

23.9

C18.89

ICD-10 Finland

Malignant overall tumor of the colon other or unspecified histology

+∞

23.9

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

23.9

1536A

ICD-9 Finland

Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]

+∞

23.9

8243/3-C18.1

ICD-O-3

Goblet cell carcinoid of appendix

+∞

23.9

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

23.9

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

23.9

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

16.4

23.8

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

23.8

361

1921

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

23.7

1277

16400

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

66.9

23.7

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

14.2

23.7

JAL00

NOMESCO Finland

Biopsy of peritoneum

14.2

23.7

L02AE03

ATC

goserelin; implant

8.1

23.6

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

238.0

23.5

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

23.5

289

1416

DAB10

NOMESCO Finland

Partial excision of auricle

41.1

23.5

N05AX08

ATC

risperidone; systemic

0.5

23.4

259

4584

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

23.1

1030

7305

A28

ICPC

Limited function/disability NOS

1.4

23.0

1334

9928

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

23.0

121

373

KBV00

NOMESCO Finland

Insertion of stent into ureter

5.7

23.0

118

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

53.6

22.9

H01CB02

ATC

octreotide; parenteral

18.3

22.8

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

22.8

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

22.8

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

22.8

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

22.8

L01CB01

ATC

etoposide; systemic

+∞

22.8

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

22.8

L02BX03

ATC

abiraterone; oral

+∞

22.8

L02BG06

ATC

exemestane; oral

+∞

22.8

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

22.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

22.5

1072

7698

C82.1

ICD-10 Finland

Follicular lymphoma grade II

228.1

22.5

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

228.1

22.5

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

39.6

22.5

JFH96

NOMESCO Finland

Other total colectomy

39.6

22.5

TJA10

NOMESCO Finland

Laparocentesis

20.5

22.4

D28

ICPC

Limited function/disability (D)

6.9

22.1

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

13.5

22.0

K83.1

ICD-10 Finland

Obstruction of bile duct

3.8

22.0

241

C18.82

ICD-10 Finland

Malignant overall tumor of colon carcinoma of adenoma

+∞

21.8

C18.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of colon

+∞

21.8

8210/3-C20.9

ICD-O-3

Adenocarcinoma in adenomatous polyp of rectum, NOS

+∞

21.8

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

21.8

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

21.8

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

21.8

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

21.8

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

21.8

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

21.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

21.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

21.7

1579

19492

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

21.7

158

600

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.2

21.6

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.8

21.5

382

2144

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

8.8

21.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

218.1

21.5

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

21.5

659

4306

KBV10

NOMESCO Finland

Removal of stent from ureter

4.9

21.5

141

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.8

21.4

150

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

21.4

774

5255

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.2

21.3

191

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

21.2

163

642

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

4.0

21.1

216

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

21.0

1114

8151

SPAT1255

SPAT

Intravenous administration of medicine

1.7

20.9

493

3012

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

20.8

1CD02

NOMESCO Finland

+∞

20.8

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

20.8

8210/3-C18.7

ICD-O-3

Adenocarcinoma in adenomatous polyp of sigmoid colon

+∞

20.8

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

20.8

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

20.8

8144/3-C20.9

ICD-O-3

Adenocarcinoma, intestinal type of rectum, NOS

+∞

20.8

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

20.8

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.4

20.7

173

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.9

20.7

220

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.1

20.6

115

372

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

208.2

20.5

WF090

NOMESCO Finland

Profylactic radiotherapy

208.2

20.5

D74

ICPC

Malignant neoplasm stomach

109.1

20.5

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

20.4

170

696

JFA70

NOMESCO Finland

Suture of small intestine

7.3

20.4

WW200

SPAT

0.6

20.4

278

4663

ZZR10

NOMESCO Finland

Flap of skin and muscle

9.7

20.3

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

41.3

20.3

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

13.4

20.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

20.1

274

1399

KBH20

NOMESCO Finland

Replantation of ureter

14.9

20.0

K62.1

ICD-10 Finland

Rectal polyp

3.2

19.9

107

337

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

11.9

19.8

8244/3-C18.1

ICD-O-3

Mixed adenoneuroendocrine carcinoma of appendix

+∞

19.7

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

19.7

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

19.7

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

19.7

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

19.7

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

35.4

19.7

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

198.3

19.5

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

16.2

19.5

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.0

19.5

114

381

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

19.4

1072

13761

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.8

19.2

124

441

KA3EB

NOMESCO Finland

Antegrade pyelography

6.5

19.2

NET99

NOMESCO Finland

Other operation on pelvis

45.6

19.1

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

4.4

19.0

156

RD211

NOMESCO Finland

1.9

19.0

292

1562

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.8

19.0

121

426

R03AC02

ATC

salbutamol; inhalant

0.8

19.0

2826

32227

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

5.7

18.9

D48.49

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum, of unknown origin

54.5

18.8

K35.1

ICD-10 Finland

Acute appendicitis with peritoneal abscess

3.4

18.8

276

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

12.6

18.7

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

18.7

L01CA04

ATC

vinorelbine; systemic

+∞

18.7

15302

ICD-8 Finland

Malignant neoplasm of large intestine, except rectum, Cacci

+∞

18.7

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

18.7

1XA03

NOMESCO Finland

+∞

18.7

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

18.7

JFA68

NOMESCO Finland

Endoscopic insertion of prosthetic tube into colon

69.3

18.6

D64.8

ICD-10 Finland

Other specified anaemias

2.6

18.6

135

515

LAE10

NOMESCO Finland

Unilateral oophorectomy

6.7

18.5

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

18.5

268

1405

M25.5

ICD-10 Finland

Pain in joint

0.8

18.5

1165

14699

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

188.3

18.5

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

38.0

18.4

C10AX09

ATC

ezetimibe; oral

0.7

18.4

460

6749

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

18.3

278

1484

JHA00

NOMESCO Finland

Anal or perianal incision

3.2

18.3

309

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

6.7

18.2

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.6

18.2

226

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.3

18.2

283

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.5

18.1

242

WX610

NOMESCO Finland

Patient controlled analgesia

6.3

18.1

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

18.1

1394

17134

JFB96

NOMESCO Finland

Other partial excision of intestine

19.1

18.0

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

10.9

18.0

R33

ICD-10 Finland

Retention of urine

1.5

18.0

668

4558

UJH02

NOMESCO Finland

Anoscopy

1.8

18.0

289

1570

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.4

17.9

255

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

32.6

17.8

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.8

17.8

1468

17901

SPAT1088

SPAT

Blood transfusion

5.5

17.7

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

17.6

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

17.6

L01AX03

ATC

temozolomide; systemic

+∞

17.6

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

17.6

3049

Kela drug reimbursment

+∞

17.6

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

17.6

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

17.6

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

17.9

17.6

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

17.6

256

1343

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

94.2

17.5

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

94.2

17.5

WGA10

NOMESCO Finland

Measurement of pain intensity

94.2

17.5

UJK02

NOMESCO Finland

ERCP

2.2

17.5

182

836

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

178.4

17.4

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.5

17.3

131

513

NK6LA

NOMESCO Finland

Bone and joint kinetic X-ray examination

12.9

17.3

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.9

17.2

102

345

D29

ICPC

Digestive symptom/complaint other

2.5

17.2

140

569

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

7.0

17.1

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

14.6

17.0

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

49.5

16.9

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

49.5

16.9

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

16.9

455

2884

B82

ICPC

Anaemia other/unspecified

2.1

16.8

196

942

JFC00

NOMESCO Finland

Entero-enterostomy

13.1

16.8

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

4.9

16.7

109

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

4.6

16.7

122

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

8.9

16.7

K63.5

ICD-10 Finland

Polyp of colon

2.8

16.7

109

393

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

16.6

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

16.6

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

16.6

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

16.6

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

16.6

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

16.6

8240/3-C18.0

ICD-O-3

Neuroendocrine tumor, NOS, of cecum

+∞

16.6

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

16.6

9680/3-C18.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of cecum

+∞

16.6

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

16.6

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

16.5

142

596

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.2

16.4

262

D07AA02

ATC

hydrocortisone; topical

1.4

16.3

809

5838

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

10.6

16.3

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

39.6

16.2

JFW98

NOMESCO Finland

Other transluminal endoscopic operation on intestine

39.6

16.2

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

14.1

16.2

R19.4

ICD-10 Finland

Change in bowel habit

2.2

16.1

169

778

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

5.8

16.1

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

11.0

16.1

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

16.1

225

1165

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

15.2

16.0

M01AC06

ATC

meloxicam; systemic, rectal

0.8

15.9

1942

22706

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

6.0

15.8

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003396) Base excess in Arterial blood by calculation

2545

11296

2.49

323.31

7.7

6.8

mmol/l

0.6

1.3

17.53

2135

8751

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2549

11320

2.49

323.31

7.7

6.8

kpa

5.2

5.1

9.87

2469

10748

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6572

42915

2.04

313.42

7.4

5.3

mmol/l

1.2

49.93

6127

37902

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4502

24713

2.21

307.65

2.3

mg/l

3.8

3.0

41.50

3914

20895

(3014111) Lactate [Moles/volume] in Serum or Plasma

2075

8281

2.71

307.65

6.7

6.5

mmol/l

1.2

1.4

10.74

2006

7949

(3044640) Blood type and Crossmatch panel - Blood

6303

25973

3.79

307.65

3.3

2.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4722

27019

2.13

307.65

4.5

2.6

u/l

36.2

35.0

0.21

4554

25280

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9810

69683

2.85

307.65

15.1

5.5

u/l

91.1

76.5

73.47

9541

64223

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5323

29031

2.37

307.65

2.8

2.3

u/l

55.6

60.5

8.05

5096

26470

(3024561) Albumin [Mass/volume] in Serum or Plasma

8057

39482

3.87

307.65

9.5

3.8

g/l

33.5

35.3

126.48

7801

35878

(3015377) Calcium [Moles/volume] in Serum or Plasma

5167

29434

2.21

307.65

7.6

2.1

mmol/l

2.3

2.4

1.14

4717

24275

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3460

17101

2.34

307.65

8.4

2.2

mmol/l

2.5

29.72

3240

14516

(3013826) Glucose [Moles/volume] in Serum or Plasma

8068

55806

2.18

307.65

6.2

4.5

mmol/l

6.9

1.17

7788

52093

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2740

1919

17.52

307.65

5.5

1.9

u/ml

1253.6

94.3

2.84

2475

1546

(3002256) Pathology report gross observation

2379

6951

3.87

307.65

1.3

1.1

—

(3032080) INR in Blood by Coagulation assay

7152

40462

2.72

307.65

9.1

10.6

inr

1.2

1.4

10.83

1830

11040

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

8772

5248

55.14

307.65

8.7

1.5

ug/l

33.0

10.2

4.16

7990

3984

(3037121) Protein [Mass/volume] in Urine

1172

3134

3.89

307.65

5.8

2.6

g/l

0.2

0.3

11.35

881

1113

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2938

13672

2.42

307.65

5.1

2.5

mmol/l

0.8

31.41

2798

12437

(3014576) Chloride [Moles/volume] in Serum or Plasma

3077

11882

3.01

307.65

8.9

6.4

mmol/l

105.3

104.2

28.23

3028

11578

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1649

4961

3.56

307.65

8.6

9.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

7966

48057

2.74

307.65

15.9

6.2

e9/l

4.0

4.4

37.22

7001

40881

(4035726)

2738

2588

12.91

307.65

1.4

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2895

9216

3.67

307.65

2.9

2.2

umol/l

8.5

8.2

0.28

2656

7921

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8701

44743

4.08

307.65

13.6

3.8

umol/l

11.5

12.3

5.78

8517

41728

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

529

739

7.19

307.65

2.1

2.0

u/ml

193.7

380.4

0.30

521

721

(3023368) Bacteria identified in Blood by Culture

5188

26086

2.61

307.65

5.1

4.0

—

(3033658) Prothrombin time (PT) actual/Normal

4898

21544

3.00

307.65

5.2

3.6

87.9

85.3

10.73

4847

20960

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5127

19938

3.57

307.65

3.1

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3139

6915

5.57

307.65

2.4

2.0

g/l

0.2

2.66

3030

6239

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2381

7591

3.53

307.65

2.4

2.2

u/l

34.9

44.5

0.81

2145

6412

(3022145) Colonoscopy Study observation

4793

9181

7.67

307.65

1.5

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3249

14003

2.70

307.65

2.2

2.6

g/l

2.4

2.3

22.23

3103

12774

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2290

9115

2.76

307.65

8.2

7.6

g/l

115.6

122.2

48.60

2235

8776

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

411

440

9.31

307.65

4.6

1.6

nmol/l

7.5

4.7

0.84

403

421

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1333

1112

12.89

307.65

5.2

1.9

u/ml

167.0

893.8

0.69

1208

1002

(3022948) Iron [Moles/volume] in Serum or Plasma

3392

15240

2.60

307.65

2.3

2.5

umol/l

10.9

12.6

28.29

3228

13884

(3016502) Oxygen saturation in Arterial blood

2419

10205

2.61

307.65

7.9

7.1

96.7

95.1

25.96

2353

9799

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3129

13102

2.76

307.65

2.2

2.6

18.4

22.3

42.32

2769

10874

(40768804) Tissue Pathology biopsy report

6102

28176

3.19

307.65

2.7

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2549

11312

2.49

307.65

7.7

6.8

kpa

14.3

11.6

94.98

2465

10732

(3003694) ABO and Rh group [Type] in Blood

4015

20801

2.29

307.65

1.4

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8028

39020

3.90

307.65

5.4

3.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7154

47465

2.11

307.65

8.4

5.8

mmol/l

1.2

69.64

6168

39692

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1731

6553

2.81

301.69

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1074

3129

3.54

291.94

2.5

3.0

u/ml

0.3

0.4

2.44

567

1848

(3000991) Gas panel - Venous blood

1919

7814

2.63

289.14

7.6

7.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

233

122

18.81

288.27

2.3

1.0

u/ml

19.1

21.7

0.20

226

111

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1573

5908

2.81

276.93

8.6

8.7

0.6

0.7

4.15

1566

5865

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1556

5957

2.75

263.38

8.7

8.5

1.2

1.4

10.40

1549

5912

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1367

4915

2.90

260.27

8.6

8.7

mmol/l

23.9

24.5

8.94

1329

4452

(40758558) Short blood count panel - Blood

3618

20307

2.03

249.24

12.5

4.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1404

5240

2.80

248.82

7.0

mmol/l

24.6

24.8

1.78

1397

5176

(3002582) Erythrocytes [#/volume] in Urine

4609

28393

1.92

240.01

3.6

3.1

e6/l

72.6

104.1

1.04

3601

21599

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5503

35946

1.88

238.55

2.9

2.8

ug/l

128.7

140.3

1.67

5091

32626

(3030467) Casts [#/volume] in Urine by Automated count

4225

26022

1.87

214.27

3.5

3.0

e6/l

0.5

1.09

3227

19423

(3042936) Bacteria identified in Isolate by Culture

2437

12682

2.07

200.43

2.2

2.1

—

(36304419) Bacteria [Presence] in Urine

4029

24888

1.84

199.15

3.4

3.0

—

(3018095) Leukocytes [#/volume] in Urine

4932

32913

1.75

184.20

4.2

3.5

e6/l

121.1

123.7

0.07

3730

23280

(3020779) Urea [Moles/volume] in Serum or Plasma

1791

8526

2.21

184.09

5.5

6.8

mmol/l

9.5

11.2

17.33

1709

8012

(3031040) Bacteria [#/volume] in Urine by Automated count

7986

61087

1.77

181.99

5.0

4.6

e6/l

2176.5

1526.4

0.33

116

996

(42870588) Differential panel, method unspecified - Blood

4523

29713

1.75

176.48

4.7

5.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

745

2371

3.17

173.62

3.4

1.5

u/ml

56.0

30.6

3.53

727

2244

(3019069) Monocytes/100 leukocytes in Blood

5774

40704

1.71

173.51

5.3

5.9

9.1

8.8

5.00

5381

37461

(3006504) Eosinophils/100 leukocytes in Blood

5749

40501

1.71

173.01

5.1

5.6

2.7

3.0

15.24

5354

37118

(3022096) Basophils/100 leukocytes in Blood

5607

39331

1.70

170.64

5.1

5.6

0.6

0.7

25.60

5217

36090

(3002030) Lymphocytes/100 leukocytes in Blood

5852

41584

1.69

169.17

5.3

5.7

23.7

26.8

76.18

5417

38002

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2625

14872

1.90

165.20

3.2

2.7

e6/l

2.6

0.00

1468

8066

(3026782) Osmolality of Urine

3060

18328

1.82

160.73

3.1

2.7

mosm/kgh2o

541.5

549.5

1.24

2699

15284

(3018010) Neutrophils/100 leukocytes in Blood

5739

41120

1.66

156.20

5.1

5.5

60.4

58.1

34.22

5349

37814

(3006315) Basophils [#/volume] in Blood

5985

43886

1.63

144.29

4.9

5.3

e9/l

0.0

17.86

4992

37349

(3001604) Monocytes [#/volume] in Blood

5942

43584

1.62

142.34

4.9

5.3

e9/l

0.6

2.05

4950

37057

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1807

9515

1.98

138.90

3.2

2.7

u/l

246.7

242.2

0.49

1717

8791

(3019198) Lymphocytes [#/volume] in Blood

6049

44755

1.61

138.28

5.0

5.4

e9/l

1.7

1.8

1.14

5160

38741

(3013115) Eosinophils [#/volume] in Blood

6090

45305

1.60

134.68

5.1

5.5

e9/l

0.2

14.51

5179

39113

(40768441) Liver Pathology biopsy report

224

344

6.40

132.54

1.1

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2027

11410

1.86

126.34

2.0

2.1

1.8

0.71

1799

9855

(3000850) Epithelial cells [#/volume] in Urine

3099

19736

1.70

126.18

2.8

2.5

e6/l

5.3

4.9

0.77

2737

17061

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2085

11973

1.83

121.39

4.8

5.4

mmol/l

1.0

3.88

1949

10952

(3018418) pH of Serum or Plasma

4005

27527

1.61

119.27

4.9

3.3

7.4

2.02

803

4841

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

603

2105

2.86

118.68

2.0

2.4

g/l

3.7

3.6

1.06

584

1993

(3026008) Bacteria identified in Urine by Culture

4211

29376

1.59

117.32

3.4

3.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2626

16323

1.71

115.42

3.1

2.6

e6/l

1.2

0.04

1457

9440

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

883

3841

2.32

110.04

2.0

1.9

ug/l

1.8

2.1

0.41

792

3316

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

708

2788

2.55

109.86

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

257

533

4.74

109.83

1.9

1.3

ug/l

18.1

19.4

0.26

249

514

(4281824)

226

428

5.18

107.37

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

54.77

106.12

1.1

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10401

90566

1.75

101.02

28.1

14.2

mg/l

37.0

24.7

199.65

9713

71798

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2515

16036

1.65

98.16

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

7833

64145

1.51

95.31

5.4

4.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

528

1976

2.66

90.66

2.1

2.4

213.6

194.8

4.83

507

1861

(3023520) Reticulocytes [#/volume] in Blood

1512

8548

1.81

90.46

2.1

2.2

e9/l

69.0

0.02

1135

6525

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

557

2143

2.59

90.43

2.0

2.1

83.1

89.0

6.94

541

1987

(3039000) Anion gap in Blood

563

2194

2.55

89.01

8.2

6.6

mmol/l

11.1

11.4

1.47

519

1978

(3018572) Chloride [Moles/volume] in Blood

563

2195

2.55

88.92

8.2

6.6

mmol/l

106.3

104.7

13.33

519

1979

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2326

14959

1.62

86.28

2.0

1.9

30.1

0.11

2274

14473

(40768795) Lymph node Pathology biopsy report

132

186

6.93

84.73

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

897

4378

2.06

83.05

6.3

4.8

1.6

1.30

845

4124

(3007930) Methemoglobin/Hemoglobin.total in Blood

887

4316

2.06

82.80

6.4

4.8

0.9

1.01

834

4061

(40768800) Prostate Pathology biopsy report

259

691

3.68

79.22

1.2

1.1

—

(3047181) Lactate [Moles/volume] in Blood

687

3112

2.20

77.06

7.4

5.8

mmol/l

1.4

1.3

0.69

620

2773

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1192

6620

1.82

74.81

8.3

7.0

mmol/l

24.5

24.6

0.65

1132

6167

(3021589) Normoblasts [#/volume] in Blood

5023

38831

1.43

74.57

15.0

8.8

e9/l

0.0

0.13

4010

31687

(3019060) Gas panel - Arterial blood

1240

6999

1.79

73.70

6.1

4.7

—

(40768793) Breast Pathology biopsy report

190

428

4.34

73.32

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

100

121

8.05

73.28

1.2

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1580

9582

1.68

72.62

3.3

3.7

kpa

5.7

5.9

11.47

1526

9286

(3012544) pH of Venous blood

1625

9956

1.67

71.77

3.4

3.7

7.4

—

(3025941) Bacteria identified in Stool by Culture

884

4535

1.95

70.80

1.3

—

(3002032) Base excess in Venous blood by calculation

1564

9569

1.67

69.26

3.3

3.7

mmol/l

1.8

1.9

0.85

1232

7787

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

343

1181

2.86

69.01

1.2

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6719

55113

1.40

68.55

3.7

3.0

u/l

67.7

49.9

23.57

6317

50153

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1517

9566

1.61

58.86

4.7

3.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1049

6024

1.75

58.13

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

833

4497

1.85

56.74

3.0

4.0

mmol/l

23.9

24.2

1.15

772

3982

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

984

5614

1.76

55.70

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

986

5662

1.74

54.52

2.5

—

(3036489) Thrombin time

601

2957

2.02

53.96

1.9

21.3

21.7

0.71

569

2599

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

843

4655

1.81

53.26

1.5

1.6

g/l

1.8

1.5

8.36

729

3955

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

538

2572

2.07

52.25

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1686

11177

1.53

52.08

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

312

1187

2.58

51.73

5.9

6.4

mg/l

12.1

0.03

277

1070

(3024354) Oxygen [Partial pressure] in Venous blood

1261

7981

1.59

47.56

3.1

kpa

4.6

4.5

1.09

1208

7705

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1662

11184

1.51

47.48

1.8

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9590

85552

1.39

46.54

28.8

13.1

ml/min/173m2

76.7

74.7

17.61

8482

68961

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

168

498

3.29

43.85

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1573

10670

1.49

42.88

1.8

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

1403

9309

1.52

42.54

1.7

2.1

ug/g

265.0

149.7

13.75

1114

7187

(3019550) Sodium [Moles/volume] in Serum or Plasma

10567

96310

1.46

41.82

33.7

17.3

mmol/l

139.3

139.7

70.02

10419

93560

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

14.74

41.76

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

8.45

41.32

2.4

2.3

u/l

915.1

4200.4

0.67

(3023103) Potassium [Moles/volume] in Serum or Plasma

10576

96529

1.45

40.30

33.8

17.4

mmol/l

4.0

44.36

10417

93628

(3004809) Band form neutrophils/100 leukocytes in Blood

278

1130

2.41

40.10

2.6

2.9

2.4

1.3

3.69

219

845

(40768797) Stomach Pathology biopsy report

1802

12698

1.44

40.08

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

410

1956

2.06

40.02

1.4

1.3

—

(3019225) pH of Specimen

1448

9850

1.48

38.64

4.7

3.7

—

(3044889) 12 lead EKG panel

7631

66529

1.29

38.30

4.4

4.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

127

5.59

38.21

1.8

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1169

7636

1.53

37.90

4.6

3.1

mmol/l

1.2

1.31

1063

6428

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

267

1102

2.37

37.25

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

273

1139

2.35

37.17

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

693

4012

1.71

36.87

1.9

1.8

—

(3051651) Icteric interference index of Serum or Plasma

148

455

3.17

36.46

5.6

4.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

266

1107

2.35

36.43

1.4

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

263

1091

2.36

36.28

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

263

1091

2.36

36.28

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

263

1095

2.35

35.99

1.4

1.3

—

(3013512) EKG study

3735

29961

1.30

35.21

4.5

4.3

—

(3002385) Erythrocyte distribution width [Ratio]

8204

72584

1.28

34.53

37.0

16.9

14.7

13.7

319.64

8107

70660

(3017181) Myelocytes/100 leukocytes in Blood

1084

7117

1.52

34.17

3.3

3.6

1.0

0.8

1.88

411

1544

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

410

2070

1.95

34.14

1.5

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

636

3698

1.70

33.27

1.8

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

6.51

32.40

6.7

1.3

—

(3049717) Cytology report of Urine Cyto stain

589

3390

1.71

31.97

2.8

1.9

—

(3009542) Hematocrit [Volume Fraction] of Blood

8813

78968

1.29

31.88

30.9

15.7

37.0

39.3

73.98

5772

50395

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8827

90964

0.78

31.63

4.3

4.8

mmol/l

4.5

1.44

7981

83280

(3021440) Promyelocytes/100 leukocytes in Blood

1037

6852

1.51

31.62

3.2

3.6

0.2

0.1

2.22

385

1442

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8737

90147

0.78

31.58

4.3

4.8

mmol/l

1.4

2.51

7822

81910

(3033799) Differential panel - Peritoneal fluid

220

3.98

31.37

1.7

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

501

2776

1.78

31.09

4.6

3.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

625

3707

1.66

30.30

4.6

4.2

mmol/l

1.3

1.4

0.92

610

3634

(40761511) CBC panel - Blood by Automated count

10204

93463

1.34

30.06

27.5

13.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

7770

68933

1.25

28.54

3.7

4.2

mm/h

17.3

12.9

76.66

7075

63070

(3023183) Ammonium ion [Moles/volume] in Plasma

365

1895

1.89

27.98

2.2

2.5

umol/l

33.6

33.1

0.11

307

1589

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10510

96904

1.35

27.91

35.5

16.5

umol/l

81.6

82.0

0.66

10505

96855

(3014765) Yersinia sp identified in Stool by Organism specific culture

449

2489

1.77

27.83

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

445

2467

1.77

27.58

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

449

2499

1.77

27.45

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

977

6559

1.48

27.43

1.3

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1031

7017

1.46

26.97

1.3

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1139

15003

0.71

26.35

1.3

iu/ml

44.8

40.0

0.40

369

4656

(3002179) Metamyelocytes/100 leukocytes in Blood

966

6528

1.47

26.19

3.0

3.5

0.8

0.6

1.91

278

1145

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2573

20320

1.28

25.82

3.7

4.1

ng/l

542.0

567.9

0.07

2170

17043

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9136

93230

0.79

25.77

4.8

5.5

mmol/l

2.6

2.14

8180

85000

(3004119) Hemoglobin [Mass/volume] in Venous blood

960

6510

1.46

25.55

3.1

3.3

g/l

121.1

129.9

24.77

937

6334

(3022217) INR in Platelet poor plasma by Coagulation assay

1991

15230

1.32

25.37

24.0

29.8

inr

1.4

1.5

2.53

293

2024

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10469

96728

1.33

25.26

18.5

9.5

u/l

24.8

25.5

3.88

10250

92178

(3021960) Folate [Moles/volume] in Serum or Plasma

3084

25009

1.26

24.67

1.6

nmol/l

20.4

20.3

0.02

2677

21098

(3030981) Hyaline casts [#/volume] in Urine by Automated count

790

5200

1.50

24.39

3.2

2.6

e6/l

0.4

0.3

0.72

781

5084

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

126

447

2.74

24.21

2.2

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1076

14107

0.71

24.01

1.2

u/ml

16.9

15.2

0.23

390

5064

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

229

1067

2.10

23.94

1.1

g/l

1.6

1.5

2.13

217

937

(3051611) Lipemic interference index of Serum or Plasma

211

962

2.14

23.35

4.9

3.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3967

33249

1.23

23.13

2.8

3.1

ng/l

1548.1

1653.5

0.74

3459

28658

(3025159) Blasts/100 leukocytes in Blood

942

6504

1.43

22.71

3.2

3.7

0.2

0.01

308

1258

(3043410) Blood group antigens tested for on Red Blood Cells

217

3.49

22.69

2.2

1.5

—

(3045142) Bone marrow Pathology biopsy report

158

649

2.37

22.46

1.3

1.2

—

(3012501) Base excess in Blood by calculation

380

2158

1.73

21.70

4.4

4.2

mmol/l

2.7

2.6

0.27

272

1450

(3013290) Carbon dioxide [Partial pressure] in Blood

380

2160

1.72

21.62

4.4

4.2

kpa

5.0

0.31

373

2097

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

21.60

1.0

0.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

259

3.19

21.44

1.5

2.4

e6/l

7486.9

714.6

0.51

182

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8521

87174

0.82

21.38

3.9

4.3

mmol/l

1.3

2.52

7563

78495

(3027315) Oxygen [Partial pressure] in Blood

381

2176

1.72

21.32

4.4

4.2

kpa

8.9

8.3

4.85

374

2112

(3021601) Nitrite [Presence] in Urine by Test strip

5268

45666

1.20

21.19

5.7

5.1

estimate

0.0

0.64

1118

7820

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8605

87920

0.82

21.13

6.3

6.6

mmol/mol

41.1

40.8

1.49

7773

80393

(3009261) Glucose [Presence] in Urine by Test strip

5327

46250

1.20

21.00

4.2

3.9

estimate

0.0

0.01

1110

7582

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2192

25553

0.79

20.57

1.6

mmol/l

1.4

1.3

3.37

1835

21020

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

338

1888

1.75

20.48

1.4

—

(3010421) pH of Blood

423

2512

1.65

20.44

4.2

4.1

7.4

0.37

373

2097

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

741

4987

1.47

20.44

2.7

1.2

0.56

734

4961

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4661

40053

1.20

20.30

3.9

4.0

ng/l

51.0

88.0

1.72

3724

29670

(3003434) Protein [Mass/volume] in Pleural fluid

235

1176

1.95

20.23

1.4

1.5

g/l

30.7

29.4

0.83

206

1035

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

726

4877

1.47

20.21

2.6

2.7

0.7

0.19

707

4660

(40760892) CBC W Ordered Manual Differential panel - Blood

2239

17848

1.26

20.13

4.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

242

1234

1.91

19.71

3.6

5.1

iu/ml

5256.1

878.9

0.48

177

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

323

1802

1.75

19.67

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

145

609

2.32

19.66

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

273

3.02

19.65

3.2

2.8

—

(3020891) Body temperature

638

4205

1.49

19.55

5.5

4.9

—

(40761536) Microorganisms panel - Urine sediment

1011

7257

1.38

19.39

4.6

4.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5032

43695

1.19

19.17

2.1

pmol/l

88.8

94.3

13.78

2966

22425

(1616796) Gas panel - Central venous blood

369

2160

1.67

18.88

3.6

3.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

226

3.18

18.65

1.5

2.2

e6/l

16617.0

18351.0

0.05

115

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

112

429

2.54

18.59

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

112

429

2.54

18.59

1.3

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

198

3.33

18.51

2.4

3.1

56.3

58.5

0.35

185

(3035350) Ketones [Presence] in Urine by Test strip

5233

45733

1.19

18.18

4.2

3.8

estimate

0.0

0.50

1090

7705

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

140

600

2.27

18.15

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

251

1333

1.84

18.06

1.4

—

(3024928) Oxygen saturation in Venous blood

359

2114

1.66

17.97

1.9

3.2

—

(3012441) Differential panel - Pleural fluid

184

882

2.03

17.94

1.4

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

359

2.63

17.30

2.5

2.4

—

(40768806) Pleura Pathology biopsy report

173

829

2.03

16.91

1.4

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1027

7547

1.34

16.89

4.0

2.5

ml/min/173m2

62.6

61.4

0.52

458

3041

(3023199) Leukocytes [#/volume] in Pleural fluid

205

1044

1.91

16.83

1.4

1.5

e6/l

1052.5

2537.3

3.21

150

770

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2394

19590

1.23

16.55

1.7

mg/l

1.9

1.3

10.03

1963

15099

(3004716) Salmonella sp identified in Stool by Organism specific culture

517

3383

1.50

16.43

1.2

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

762

5379

1.39

16.13

3.7

3.3

mmol/l

24.7

25.3

3.93

737

5216

(3044007) Cell count panel - Peritoneal fluid

211

3.08

16.10

1.6

2.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

187

941

1.94

15.94

1.4

1.5

e6/l

108392.7

57427.2

0.56

116

564

(3019309) Folate [Moles/volume] in Red Blood Cells

2624

21770

1.21

15.68

1.8

nmol/l

1166.5

1157.0

0.18

1983

16233

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

264

2.79

15.37

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

348

2117

1.61

15.35

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

348

2118

1.61

15.32

1.2

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

418

2654

1.54

15.32

1.4

ug/g

252.1

281.1

2.12

265

1571

(3007164) IgA [Mass/volume] in Serum or Plasma

1843

14785

1.24

15.23

1.4

1.3

g/l

2.6

2.7

0.79

1014

8281

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

261

2.79

15.12

1.5

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

261

2.79

15.12

1.5

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

363

2.49

14.94

1.5

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

363

2.49

14.94

1.5

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

363

2.49

14.94

1.5

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

487

3211

1.49

14.93

5.1

4.5

mmol/l

3.8

3.9

5.53

454

3020

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

268

1538

1.70

14.86

3.6

3.3

59.2

58.8

0.17

268

1538

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

182

932

1.90

14.76

1.8

2.4

u/ml

587.6

9541.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

364

2.45

14.38

1.5

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

879

6463

1.34

14.37

3.7

3.5

kpa

5.1

5.2

2.79

817

5927

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

292

1733

1.64

14.26

1.4

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

841

6152

1.35

14.23

3.7

3.4

mmol/l

1.9

0.04

607

4518

(3009343) pH of Capillary blood

867

6376

1.34

14.16

3.7

3.5

7.4

0.63

115

792

(3045788) Cell count panel - Pleural fluid

159

791

1.96

14.07

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

155

767

1.97

13.94

1.3

1.4

mmol/l

6.6

0.10

145

699

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

698

4977

1.38

13.91

4.5

4.0

46.8

47.4

0.27

690

4913

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

543

3710

1.43

13.86

2.0

2.3

ug/l

392.4

678.0

2.42

527

3479

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

158

790

1.95

13.79

1.3

u/l

702.4

333.6

0.43

149

735

(3028626) Oxygen [Partial pressure] in Capillary blood

354

2220

1.56

13.76

3.5

2.8

kpa

8.0

7.9

0.65

334

2057

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

5.77

13.66

1.0

ug/l

2.2

0.00

(3021879) Hepatitis B virus core Ab [Presence] in Serum

582

4038

1.41

13.64

1.2

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

334

2077

1.57

13.48

2.6

2.5

15.5

16.3

2.90

169

1102

(3007461) Platelets [#/volume] in Blood

10648

99938

1.24

13.35

43.4

20.8

e9/l

250.4

242.1

25.85

10416

96501

(3026692) Albumin [Mass/volume] in Peritoneal fluid

204

2.90

13.28

1.2

1.6

g/l

14.4

13.8

0.22

146

(3024731) MCV [Entitic volume]

10650

99980

1.24

13.19

43.2

20.7

91.1

91.5

16.97

10535

97925

(3035941) MCH [Entitic mass]

10649

99972

1.24

13.17

43.2

20.7

30.0

30.5

88.32

10532

97921

(3026361) Erythrocytes [#/volume] in Blood

10650

99987

1.24

13.13

43.3

20.8

e12/l

4.3

4.5

306.73

10379

96104

(3000963) Hemoglobin [Mass/volume] in Blood

10651

99999

1.24

13.12

43.7

20.9

g/l

126.4

135.7

307.65

10536

97949

(3010813) Leukocytes [#/volume] in Blood

10650

100001

1.24

13.02

43.4

20.8

e9/l

6.9

6.8

6.01

10392

96142

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6696

68862

0.87

12.97

3.5

3.8

pmol/l

15.0

0.58

5917

61461

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2128

17586

1.21

12.94

1.2

u/ml

2.2

1.8

0.56

533

4550

(3017354) Segmented neutrophils/100 leukocytes in Blood

151

772

1.90

12.39

2.5

2.8

60.3

61.0

0.13

498

(3028271) Lactate [Moles/volume] in Capillary blood

258

1541

1.63

12.35

1.9

mmol/l

1.8

1.7

0.70

253

1508

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

7.26

12.16

6.2

3.1

umol/l

0.3

0.4

0.55

(3042111) Morphology [Interpretation] in Bone marrow Narrative

208

1186

1.71

11.90

1.5

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

159

842

1.84

11.72

3.0

2.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2740

23331

1.17

11.70

4.5

3.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

258

2.56

11.68

1.4

2.7

2.5

0.06

213

(3021901) Oxygen saturation in Capillary blood

304

1925

1.54

11.39

2.9

2.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

433

2949

1.44

11.30

5.2

4.4

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

4.26

11.29

2.1

2.4

59.8

63.3

0.18

(3000494) Fungus identified in Specimen by Culture

1299

10349

1.24

11.25

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

338

2197

1.50

11.21

1.2

titre

70.5

145.7

1.74

190

(3008757) Leukocyte morphology finding [Identifier] in Blood

154

829

1.81

10.80

2.8

3.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

398

2.17

10.61

1.8

2.1

33.0

45.5

—

(1761868) Lipid panel - Serum or Plasma

2576

28081

0.86

10.55

3.0

3.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

386

2.16

10.18

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

386

2.16

10.18

1.3

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

134

707

1.84

10.07

1.4

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

376

2554

1.44

10.00

3.8

3.3

mmol/l

1.6

0.10

367

2492

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

128

668

1.86

9.96

1.4

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

128

668

1.86

9.96

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

128

668

1.86

9.96

1.4

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

969

11487

0.80

9.81

1.3

titre

528.3

550.8

0.12

192

2589

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

299

2.30

9.81

1.4

53.7

65.1

1.60

237

(40761539) Cells [Type] in Urine sediment by Light microscopy

201

2.60

9.71

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

158

887

1.73

9.66

1.4

1.5

—

(4034850)

229

3388

0.65

9.63

13.5

11.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

143

2.91

9.56

2.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1045

8284

1.24

9.45

1.4

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

328

2199

1.45

9.38

1.2

titre

355.7

993.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

299

2.27

9.37

2.1

2.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

255

2.36

9.07

1.3

mmol/l

3.3

3.1

0.26

228

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

157

899

1.70

8.97

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

131

714

1.78

8.91

1.5

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

103

3.20

8.86

3.8

1.5

u/l

59.0

75.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

367

2544

1.41

8.77

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9114

90963

0.88

8.70

4.7

5.1

mmol/l

6.1

4.61

8169

81804

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

317

2.17

8.58

2.0

1.9

15.1

16.1

0.17

136

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

220

2.42

8.57

1.2

1.3

ug/l

963.9

45.8

1.14

100

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

435

3114

1.36

8.57

2.3

2.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

256

2.31

8.55

5.7

1.1

u/ml

36.0

233.0

2.51

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

760

9113

0.79

8.50

1.5

—

(3022313) Gas panel - Capillary blood

610

4595

1.30

8.45

3.9

3.6

—

(3035880) pH of Pleural fluid

483

1.93

8.42

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

391

2.03

8.37

1.8

1.4

mg/l

4.3

4.1

0.14

370

(3011412) CD3 cells [#/volume] in Blood

446

1.96

8.26

2.0

e9/l

1.1

1.0

0.23

248

(21494814) CD8 cells/100 lymphocytes in Specimen

172

2.59

8.26

2.0

—

(3017732) Neutrophils [#/volume] in Blood

775

6048

1.26

8.08

4.2

3.0

e9/l

4.2

4.1

0.39

586

4337

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

136

772

1.71

8.07

1.5

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.91

8.07

2.8

1.2

ng/l

57.7

114.6

—

(3000330) Specific gravity of Urine by Test strip

707

5461

1.27

8.04

5.3

3.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

112

603

1.80

7.98

1.3

u/l

14.3

11.7

0.41

542

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

3.84

7.88

2.1

2.3

14.7

11.8

0.16

(3000919) Neutrophils/100 leukocytes in Pleural fluid

235

2.31

7.88

1.4

29.4

21.9

0.98

208

(21494755) Public health laboratory ask at order entry panel

354

4642

0.73

7.75

1.3

1.4

—

(3015736) pH of Urine

4020

35957

1.12

7.72

3.8

3.6

5.8

5.3

—

(3038515) Glucose [Moles/volume] in Venous blood

346

2440

1.38

7.53

4.0

3.4

mmol/l

7.6

7.8

1.08

341

2383

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

242

3365

0.69

7.51

1.4

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

291

1993

1.42

7.51

1.1

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

377

2699

1.36

7.47

2.9

3.0

mmol/l

24.2

24.8

1.75

330

2383

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1211

9972

1.19

7.45

2.9

3.1

ng/l

227.4

238.7

0.41

1100

9155

(3019977) pH of Arterial blood

109

597

1.77

7.37

3.1

2.3

7.4

0.56

210

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

122

692

1.71

7.31

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

840

0.40

7.21

1.0

ng/l

37.2

44.9

0.67

550

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

179

1123

1.55

7.17

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

837

0.40

7.15

1.0

ng/l

622.1

708.2

0.95

533

(3033705) Calcium.ionized [Moles/volume] in Venous blood

222

1459

1.48

7.14

2.9

2.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

244

3349

0.70

7.07

1.1

1.2

u/ml

3.0

0.7

0.68

304

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

832

0.41

7.06

1.0

ng/l

261.5

353.2

2.74

555

(1002224) Polysomnography panel

196

2799

0.67

7.04

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1013

8257

1.20

6.97

2.4

1.7

g/l

64.9

66.7

9.70

903

7324

(3044242) Glucose [Moles/volume] in Arterial blood

509

1.81

6.94

2.1

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

517

3915

1.29

6.94

4.2

3.8

mmol/l

24.7

24.9

0.50

462

3562

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4334

39113

1.11

6.87

4.9

4.0

ug/l

3.1

2.4

1.53

3782

34925

(3006184) Hemoglobin [Mass/volume] in Capillary blood

331

2363

1.36

6.73

2.3

2.2

g/l

121.7

130.0

7.33

252

1727

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

260

2.13

6.63

1.9

2.2

—

(4010399)

605

7226

0.80

6.56

1.4

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

527

1.75

6.22

1.7

2.0

u/field

2.3

2.4

0.06

353

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

108

625

1.68

6.09

2.0

1.7

u/l

202.9

2026.5

2.73

236

(3020393) Adenovirus Ag [Presence] in Stool

2.96

6.06

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

124

2.58

5.96

1.4

15.7

9.1

0.42

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

140

869

1.56

5.96

1.7

2.2

u/field

2.6

2.1

0.40

315

(3002331) Protein [Mass/volume] in Peritoneal fluid

177

2.30

5.95

1.2

1.5

g/l

26.8

58.3

0.47

137

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

193

1285

1.46

5.90

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

214

1459

1.43

5.77

1.3

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4177

37880

1.10

5.74

2.2

nmol/l

76.2

78.9

7.57

3706

32915

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

447

1.78

5.74

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.15

5.72

1.5

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

424

5178

0.78

5.61

1.3

au/ml

64.3

50.1

0.52

213

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3097

32303

0.90

5.61

2.1

2.2

u/l

227.0

230.1

0.06

2916

30062

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

143

905

1.53

5.61

1.1

1.2

u/l

83.4

56.5

1.00

575

(3045414) Leukocytes [Presence] in Urine

549

4303

1.24

5.60

2.1

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

444

1.77

5.58

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

385

4746

0.78

5.51

1.2

1.3

u/ml

222.4

229.9

0.07

345

4362

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

171

1129

1.47

5.49

1.3

—

(3045424) Erythrocytes [Presence] in Urine

226

1572

1.40

5.46

1.7

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

106

1625

0.63

5.43

1.1

1.2

u/ml

50.6

48.8

—

185

(3003181) Sodium [Moles/volume] in Urine

256

1820

1.37

5.43

1.4

mmol/l

57.8

64.0

1.58

179

1469

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

198

2.15

5.37

1.3

1.4

21.9

25.4

0.33

162

(3008898) HLA-B27 [Presence]

147

2092

0.68

5.29

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

+∞

5.14

1.0

0.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

482

5733

0.81

5.09

2.3

2.4

au/ml

33.9

26.9

0.32

203

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

179

2437

0.71

5.07

1.3

1.6

mg/l

3.3

3.9

0.42

148

1725

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

539

1.66

5.03

1.3

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1309

0.60

5.02

3.8

4.4

umol/l

335.6

351.9

0.50

1076

(3017569) Oxygen content in Arterial blood

518

1.67

4.99

2.2

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

12.90

4.97

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

107

653

1.59

4.97

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

433

5193

0.80

4.94

1.8

1.9

—

(4094501)

207

2737

0.73

4.92

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

404

1.75

4.91

1.5

5.1

mg/l

61.8

684.1

0.51

275

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

550

1.64

4.91

1.5

u/l

5.9

6.4

0.09

240

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8464

84057

0.91

4.87

4.3

4.7

mu/l

2.7

2.1

0.82

7494

75584

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.06

4.83

1.1

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

4.30

4.79

1.2

1.1

u/field

1.0

0.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

539

1.64

4.79

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

194

1348

1.40

4.78

1.2

—

(40765096) Chromosome analysis panel by Banding

121

2.40

4.74

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

867

7220

1.17

4.72

2.3

1.8

nmol/l

407.6

369.9

5.20

810

6463

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

487

3845

1.23

4.70

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

274

2016

1.32

4.69

1.6

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

237

3043

0.75

4.66

1.4

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

101

619

1.58

4.64

2.5

2.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2530

22587

1.10

4.63

3.5

3.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.55

4.48

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

257

1889

1.32

4.45

1.5

1.6

—

(3019150) Specific gravity of Urine by Refractometry

2010

21204

0.90

4.40

4.4

kg/l

1.0

0.14

351

3266

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

271

3385

0.77

4.38

1.4

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

2805

25235

1.10

4.35

4.5

4.3

estimate

0.0

0.40

1014

7537

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

133

2.26

4.30

2.0

1.1

ug/l

2.3

2.5

0.06

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

356

1.74

4.29

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.83

4.16

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

170

2252

0.73

4.16

1.6

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

1156

1.39

4.10

1.3

1.4

—

(3022475) Manganese [Moles/volume] in Blood

3.75

4.03

1.6

1.2

—

(36660697) Celiac disease serology panel - Serum

767

6411

1.17

4.03

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.49

3.98

1.2

—

(3036603) Volume of Urine

561

1.56

3.91

1.7

1.4

1840.9

1958.9

0.35

144

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

449

1.62

3.86

1.1

u/l

85.2

87.7

0.11

346

(3000060) B lymphocytes [#/volume] in Blood

2.45

3.84

1.7

1.9

e6/l

1495.7

158.2

0.47

(40758292) HTLV I+II Ab panel - Serum

2.98

3.84

1.4

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

363

1.68

3.77

2.0

e6/l

486.3

699.6

1.91

159

(3042631) Mycobacterium sp identified in Specimen

176

1257

1.36

3.76

2.1

2.9

—

(44806118)

126

850

1.44

3.75

1.3

1.4

—

(44790047)

126

851

1.44

3.73

1.3

1.4

—

(44790049)

126

851

1.44

3.73

1.3

1.4

—

(44790048)

126

851

1.44

3.73

1.3

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

217

2727

0.77

3.73

1.7

1.6

e6/l

16451.8

14342.4

0.22

159

1993

(3005719) IgG [Mass/volume] in Serum or Plasma

682

5686

1.17

3.72

2.6

2.2

g/l

10.2

10.9

3.23

621

5155

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

105

2.30

3.68

1.4

1.2

u/l

32.3

362.3

0.49

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

449

1.60

3.63

1.1

u/l

33.1

23.3

0.75

330

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

112

2.25

3.62

2.8

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

234

2894

0.78

3.57

1.4

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

187

2381

0.76

3.56

1.2

u/ml

32.4

42.7

—

147

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

411

3292

1.21

3.55

2.6

1.6

mg/l

38.5

37.4

0.14

344

2633

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.51

3.54

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.34

3.52

1.0

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

289

2236

1.26

3.46

2.4

2.2

—

(21494434) Karyotype in Bone marrow

103

681

1.47

3.44

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

627

0.54

3.41

1.2

1.4

pmol/l

123.7

120.3

—

190

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

915

9950

0.88

3.39

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

398

3194

1.21

3.38

2.7

1.6

ratio

1.4

2.3

1.70

246

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

265

1.75

3.38

2.9

2.5

31.9

42.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

410

3306

1.21

3.33

2.6

1.6

mg/l

72.2

48.0

0.94

344

2654

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

231

1.80

3.32

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1255

13375

0.90

3.31

11.5

7.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

175

2222

0.76

3.30

1.2

1.3

u/ml

3.0

4.9

1.88

380

(3045683) HLA typing for celiac disease panel - Blood or Tissue

363

1.63

3.28

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

143

1866

0.74

3.26

1.1

1.2

mmol/l

3.8

3.9

0.52

137

1749

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2527

22896

1.08

3.25

1.7

pmol/l

22265314.1

29974968.4

0.32

2084

18459

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

174

2197

0.76

3.16

1.2

1.3

u/ml

7.3

7.5

0.02

247

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

272

2114

1.25

3.16

3.1

2.6

mg/l

1.8

1.7

0.56

245

1871

(3052592) Norovirus Ag [Presence] in Stool

207

1.82

3.14

1.4

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

408

3310

1.20

3.12

1.1

u/ml

8.7

6.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

6.16

3.10

1.1

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

306

2416

1.23

3.09

2.4

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

350

4068

0.83

3.08

1.2

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

532

1.49

3.05

2.1

ug/min

43.4

160.0

1.85

136

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

153

1951

0.76

3.01

1.3

1.4

—

(3004451) EKG impression Narrative

511

1.50

2.99

1.2

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

328

1.62

2.96

3.7

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

328

1.62

2.96

3.7

2.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.15

2.89

1.8

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

155

1138

1.32

2.85

1.1

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.80

2.84

1.1

1.3

u/field

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

829

7156

1.13

2.82

2.2

1.5

—

(3014271) Vancomycin [Susceptibility]

670

1.42

2.82

3.0

3.1

—

(3045716) Anion gap in Serum or Plasma

511

1.48

2.80

2.7

2.1

mmol/l

9.0

0.02

382

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

185

2276

0.78

2.79

1.5

1.7

nmol/l

40.6

44.7

2.17

174

2172

(3017446) Testosterone [Moles/volume] in Serum or Plasma

644

5474

1.15

2.79

2.0

2.2

nmol/l

10.8

14.7

23.25

547

4753

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

121

860

1.36

2.77

1.0

1.1

u/ml

4.6

4.1

0.07

312

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

147

1860

0.76

2.76

1.4

e6/l

241.8

1672.3

3.98

121

1545

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

224

2690

0.80

2.75

1.5

1.7

—

(3000012) Reticulocyte production index

569

1.45

2.74

1.3

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

147

1857

0.76

2.74

1.3

1.4

e6/l

14.2

24.1

0.52

117

1457

(3042010) Triglyceride [Moles/volume] in Pleural fluid

120

2.02

2.73

1.4

1.2

mmol/l

2.4

1.7

0.20

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4880

45511

1.06

2.65

2.3

2.4

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.96

2.64

1.0

1.1

22.1

21.6

0.10

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.96

2.64

1.0

1.1

36.4

36.6

0.07

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.96

2.64

1.0

1.1

9.0

8.9

0.01

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2381

21691

1.08

2.63

3.1

2.8

ug/l

0.8

0.7

2.67

1688

15045

(3002619) Bacteria identified in Specimen by Culture

178

1.79

2.58

1.3

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.76

2.58

2.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

103

2.07

2.57

1.5

1.3

25.1

24.6

0.02

(3000093) Morphology [Interpretation] in Blood Narrative

120

866

1.34

2.53

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

382

1.52

2.50

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

172

1307

1.28

2.50

1.1

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

479

4026

1.16

2.47

2.2

1.4

g/l

7.5

0.24

344

2931

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

259

2065

1.22

2.46

1.1

u/ml

4.5

9.4

1.07

174

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

478

4022

1.16

2.43

2.2

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

477

4015

1.15

2.42

2.2

1.4

g/l

3.8

3.9

0.96

324

2828

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

226

1.67

2.40

2.0

u/ml

2929.4

52615.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

364

0.50

2.40

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

532

4517

1.15

2.39

2.0

1.5

g/l

1.6

1.2

1.59

485

4064

(3048879) Bone marrow aspiration report

234

1.66

2.38

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

237

1881

1.22

2.37

1.2

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

401

4490

0.86

2.35

1.1

1.2

iu/ml

128.1

132.5

0.07

122

1643

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

107

1.99

2.35

1.2

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

152

1869

0.78

2.35

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

213

1.68

2.34

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

160

1220

1.27

2.29

1.2

1.3

nmol/l

0.6

2.8

1.01

151

1164

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

649

0.64

2.28

1.1

—

37.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

777

0.67

2.28

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.47

2.28

2.3

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3792

35236

1.06

2.25

4.7

4.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

634

1.38

2.25

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

160

1224

1.27

2.24

1.2

nmol/l

0.2

0.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.21

2.23

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

263

3033

0.83

2.22

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

137

1.84

2.22

1.0

1.2

ng/l

91.3

148.9

0.85

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

444

3746

1.15

2.21

2.3

1.5

g/l

3.2

3.1

1.60

332

2885

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

117

1473

0.77

2.20

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

145

1099

1.28

2.20

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.00

2.17

1.8

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

158

1213

1.26

2.16

1.3

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

209

1656

1.22

2.15

3.0

3.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

321

2647

1.18

2.15

3.1

nmol/l

0.8

0.19

253

2054

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

508

0.61

2.13

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

327

1.51

2.11

1.9

e6/l

558.7

429.6

1.02

279

(3020682) Albumin/Creatinine [Ratio] in Urine

3446

34677

0.95

2.09

4.1

4.0

mg/mmol

11.1

9.0

1.09

2262

22014

(3022621) pH of Urine by Test strip

751

6574

1.11

2.08

3.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

194

1534

1.23

2.06

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

585

0.64

2.05

1.6

1.8

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

113

1.88

2.05

1.4

1.2

ug/l

42.3

120.6

6.29

(3014148) Varicella zoster virus Ab [Titer] in Serum

701

0.67

2.05

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.53

2.04

1.9

2.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

105

771

1.32

2.04

1.2

97.8

94.9

0.58

718

(40762814) Titanium [Mass/volume] in Blood

253

0.46

2.03

2.3

ug/l

3.2

—

(36303858) Crystals [Presence] in Urine

4.84

2.01

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

168

2000

0.81

2.00

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

852

7528

1.10

1.98

3.5

3.8

ng/l

98.3

96.6

0.20

745

6284

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

371

3119

1.15

1.97

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.29

1.97

5.8

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

151

1.73

1.94

1.8

34.2

26.7

1.26

140

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1094

0.75

1.92

1.6

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

146

1130

1.25

1.91

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

224

2577

0.84

1.90

1.5

1.6

iu/ml

2.7

3.5

0.11

584

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

204

1.61

1.90

1.1

1.3

umol/l

1.7

2.9

3.71

190

(3009871) Measles virus Ab [Titer] in Serum

219

0.44

1.89

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

336

1.47

1.89

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

595

0.67

1.87

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

482

1.39

1.87

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

257

0.49

1.87

4.1

6.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

594

0.67

1.86

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

450

1.40

1.86

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

685

0.69

1.85

1.2

2.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

593

0.67

1.84

1.1

—

(3012516) Albumin [Mass/volume] in Urine

3262

32775

0.95

1.84

3.3

3.2

mg/l

322.1

299.0

0.13

2206

20839

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

451

1.40

1.84

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

517

1.37

1.83

2.5

2.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

441

3776

1.13

1.82

2.2

1.4

g/l

10.2

10.3

0.21

361

3123

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

590

0.67

1.80

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

590

0.67

1.80

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

111

1365

0.78

1.80

1.6

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

156

1226

1.23

1.80

8.4

12.9

mmol/l

7.1

7.5

1.03

137

1008

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.48

1.79

3.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.48

1.79

7.2

7.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

139

1664

0.81

1.78

1.7

1.8

pmol/l

195.5

197.0

0.07

130

1556

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.56

1.78

1.0

nmol/l

195.6

270.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

588

0.67

1.78

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

138

1073

1.25

1.76

1.2

1.3

nmol/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

219

2504

0.84

1.75

1.3

1.5

g/l

0.2

0.13

207

2355

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

310

1.47

1.75

1.9

e9/l

0.2

0.44

276

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1011

0.75

1.74

1.2

mmol/l

7.5

7.7

0.19

694

(3044941) Cell count panel - Synovial fluid

146

1732

0.81

1.73

1.4

—

(44813793)

537

0.67

1.71

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

501

1.35

1.67

1.2

u/l

39.5

23.2

0.90

423

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.72

1.66

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.36

1.63

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

158

1846

0.83

1.63

1.1

1.2

u/ml

4.3

6.0

0.27

153

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

520

1.34

1.63

1.2

u/l

172.9

90.6

0.76

448

(3006270) Folate [Moles/volume] in Blood

123

955

1.25

1.61

1.3

1.2

nmol/l

322.8

331.1

0.15

752

(21494890) Protein electrophoresis panel - 24 hour Urine

123

956

1.25

1.60

1.9

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.06

1.58

1.2

1.4

ml/s/173m2

0.5

0.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

116

900

1.25

1.55

1.3

—

44.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1020

0.78

1.51

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

227

2550

0.86

1.51

1.4

1.5

g/l

1.1

1.2

1.02

214

2395

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

133

1052

1.22

1.50

1.2

u/ml

2.9

4.2

1.38

476

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.25

1.49

2.8

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

3332

33298

0.96

1.48

3.2

mmol/l

7.5

7.4

0.92

2741

27702

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

203

1.53

1.47

1.3

1.2

—

(3014891) Appearance of Pleural fluid

157

1.60

1.47

2.0

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

402

0.65

1.46

1.1

ratio

1.1

—

139

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

173

1.57

1.44

1.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

574

1.30

1.43

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

515

0.69

1.43

1.4

2.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

415

1.35

1.43

4.9

6.6

mmol/l

24.6

25.2

0.39

374

(3006442) Creatine [Moles/volume] in Serum or Plasma

635

1.28

1.41

1.4

1.7

umol/l

81.8

70.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

153

1236

1.20

1.41

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

114

1352

0.81

1.41

1.2

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

147

1700

0.83

1.40

1.6

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

965

0.78

1.40

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

374

0.65

1.39

1.3

1.1

—

(3022689) Creatine [Moles/volume] in Urine

315

0.61

1.39

1.3

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

560

1.30

1.39

1.4

1.5

umol/l

14.9

13.9

0.38

523

(3003338) MCHC [Mass/volume]

7802

74337

1.04

1.37

38.8

18.7

g/l

329.1

332.1

138.49

7741

73646

(3008401) Mugwort IgE Ab [Units/volume] in Serum

810

0.76

1.37

1.0

1.1

u/ml

1.9

1.0

0.60

309

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

134

1073

1.21

1.36

1.2

u/ml

4.9

4.1

0.19

367

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.15

1.35

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

463

0.69

1.35

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.1

—

0.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

146

1.59

1.33

1.3

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

144

1657

0.84

1.32

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.84

1.31

2.8

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3330

31220

1.04

1.31

4.3

3.9

21.6

24.3

19.72

1707

15404

(3026470) Cobalt [Mass/volume] in Blood

856

0.78

1.29

1.9

ug/l

3.8

3.9

0.05

761

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

514

0.71

1.28

1.2

1.1

mg/l

40.9

41.1

0.01

439

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

952

0.79

1.28

1.1

u/ml

2.9

1.2

0.35

363

(3047189) Immunofixation for 24 hour Urine

341

1.36

1.26

1.5

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

172

1.52

1.25

1.4

1.2

mmol/l

1.5

1.4

0.24

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

383

3343

1.11

1.24

2.4

1.5

g/l

1.0

0.5

1.54

317

2804

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

698

0.76

1.23

1.2

—

(3006462) Nitrate [Presence] in Urine

478

1.30

1.22

4.2

3.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

182

0.53

1.20

2.6

3.0

mg/l

7.6

6.7

—

148

(3003888) Timothy IgE Ab [Units/volume] in Serum

835

0.79

1.19

1.0

1.1

u/ml

7.3

3.2

0.70

372

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

158

1306

1.17

1.5

—

(3049242) von Willebrand panel - Platelet poor plasma

2.55

1.17

1.0

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

142

1614

0.85

1.16

1.3

1.4

—

(3025577) Chromium [Mass/volume] in Blood

832

0.79

1.16

2.0

ug/l

2.1

2.3

0.27

694

(3000492) Spirometry study

750

7758

0.93

1.15

1.4

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1023

0.81

1.15

1.1

au/ml

9.9

13.7

—

(3042733) HLA Ab [Presence] in Serum

239

0.61

1.13

2.7

5.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

122

990

1.19

1.13

3.7

3.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

688

0.77

1.13

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

262

0.63

1.12

1.2

1.1

—

(4211845)

519

1.27

1.12

4.1

3.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1051

0.82

1.12

1.5

30.3

28.3

0.19

675

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.98

1.10

1.0

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2603

25987

0.96

1.10

2.8

2.5

umol/l

4960.9

5894.3

0.51

2245

21965

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

824

0.80

1.09

1.1

—

22.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

504

1.27

1.09

2.2

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

823

0.80

1.08

1.4

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

294

0.66

1.08

1.1

95.0

97.6

0.11

226

(4015189)

328

0.68

1.07

2.0

2.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

232

2527

0.89

1.07

1.6

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

529

0.75

1.07

1.8

1.4

u/l

4.6

6.0

2.57

441

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

336

2942

1.11

1.06

2.5

1.5

g/l

0.1

0.0

0.45

297

2652

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

358

3147

1.10

1.05

2.3

1.5

g/l

36.5

37.3

1.53

289

2628

(42529582) MDA5 Ab [Presence] in Serum by Line blot

267

0.65

1.02

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

267

0.65

1.02

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

267

0.65

1.02

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

267

0.65

1.02

1.1

—

(3028300) Cannabinoids [Presence] in Urine

1070

0.83

1.01

1.3

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

131

1083

1.17

1.01

1.3

1.5

u/ml

99.8

119.0

1.45

229

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

104

0.46

1.01

1.8

1.9

umol/l

11.2

18.2

—

104

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.99

0.99

1.3

1.4

—

(3007916) DNA double strand Ab [Titer] in Serum

131

0.52

0.98

1.0

1.3

—

87.2

—

(3027008) Opiates [Presence] in Urine

1065

0.83

0.97

1.3

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

205

0.61

0.97

1.5

2.0

mg/l

12.3

9.1

—

161

(3000034) Microalbumin [Mass/volume] in Urine

124

1025

1.17

0.97

3.3

3.0

mg/l

49.0

41.9

0.13

745

(3023511) Choriogonadotropin [Units/volume] in Urine

286

0.68

0.97

1.6

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.1

—

0.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

606

0.78

0.96

1.0

u/ml

5.4

2.9

0.38

231

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

262

0.66

0.95

1.4

1.6

ug/l

11.7

9.0

0.91

262

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

127

1425

0.86

0.94

1.6

1.5

61.6

60.6

0.10

911

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

169

1858

0.88

0.94

1.6

1.7

iu/l

6.6

4.5

0.65

610

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

272

0.67

0.93

1.0

1.3

—

24.4

—

(3004616) Nuclear Ab [Presence] in Serum

103

1174

0.85

0.93

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

121

1.52

0.93

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

604

1.22

0.92

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

456

1.25

0.92

1.3

1.6

—

(4027681)

361

0.72

0.91

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

414

1.26

0.90

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

490

0.77

0.88

1.1

1.0

u/ml

1.7

0.2

—

117

(3010144) Erythrocytes [#/volume] in Synovial fluid

1084

0.85

0.88

1.5

1.3

e6/l

121064.9

165223.4

0.28

742

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

391

0.74

0.87

1.2

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

1062

0.85

0.87

1.3

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.00

0.87

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

925

0.84

0.86

1.6

u/ml

27.1

26.1

0.07

220

(3024263) Appearance of Synovial fluid

564

0.79

0.86

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

103

1164

0.85

0.86

1.1

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

172

1.41

0.85

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

699

1.19

0.84

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

140

1.45

0.84

2.4

2.8

u/field

1.0

0.5

0.82

140

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.93

0.84

1.2

1.0

u/ml

0.1

—

(3020491) Glucose [Moles/volume] in Blood

700

0.81

0.84

1.5

2.1

mmol/l

7.5

7.0

0.56

463

(3016879) Cocaine [Presence] in Urine

994

0.85

0.83

1.3

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.66

0.83

1.2

1.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

794

0.83

1.1

—

52.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1116

10331

1.05

0.82

2.2

2.5

ug/l

5.3

7.8

5.71

930

8881

(3001964) Herpes simplex virus Ag [Presence] in Specimen

207

1.36

0.81

1.2

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

311

2759

1.09

0.81

2.4

1.5

g/l

0.0

0.70

272

2479

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.69

0.81

1.7

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.68

0.79

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

607

1.20

0.79

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

361

0.75

0.78

1.0

1.1

u/l

2.3

1.0

0.47

166

(3008295) Osmolality of Serum or Plasma

103

858

1.16

0.78

1.2

1.4

mosm/kgh2o

273.8

276.3

0.52

638

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

204

0.66

0.78

1.3

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

151

1.41

0.78

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.78

0.0

1.0

—

(4268621)

715

1.18

0.77

2.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.50

0.77

1.0

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

777

0.83

0.77

1.3

titre

92.2

443.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

119

1005

1.15

0.75

1.2

1.1

112.4

115.4

0.52

107

897

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.10

0.75

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

496

1.21

0.74

1.3

u/l

39.0

33.4

0.50

350

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

169

1.37

0.74

1.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

152

1309

1.12

0.72

1.9

2.2

mg/l

41.7

26.8

1.10

340

(3028717) Thiamine [Mass/volume] in Blood

1.55

0.72

1.0

1.1

—

(4212803)

1.55

0.72

1.1

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.78

0.72

1.1

1.4

5.1

2.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

411

1.22

0.71

2.3

2.6

—

25.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

321

0.75

0.70

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

152

1313

1.12

0.70

1.4

1.3

u/l

16.3

9.5

4.04

115

1039

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

407

0.78

0.69

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

334

1.25

0.69

1.5

1.7

nmol/l

5.1

4.9

0.03

283

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

114

1.44

0.69

1.9

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

209

0.69

0.68

1.3

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

698

1.16

0.68

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

185

0.68

0.66

1.5

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

169

1475

1.11

0.66

1.1

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

391

3540

1.07

0.66

1.1

titre

155.5

198.6

0.28

(3024932) HLA-DR beta [Type]

207

0.70

0.66

1.1

—

(4306422)

121

1037

1.13

0.65

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

228

0.72

0.64

1.6

ng/l

148.8

122.4

0.23

228

(40761535) Cells panel - Urine sediment

859

8661

0.96

0.64

3.6

3.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.73

0.64

1.6

1.0

—

(3016750) Collection duration of Urine

640

1.16

0.63

2.4

2.1

min

503.9

500.5

0.12

481

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

571

0.83

0.63

1.2

1.3

u/ml

0.2

1.2

3.02

307

(3027944) Amphetamines [Presence] in Urine

1037

0.88

0.62

1.3

1.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.67

0.61

4.4

7.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

161

1410

1.11

0.61

1.2

1.3

iu/l

40.4

33.9

1.32

130

1217

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

122

1320

0.89

0.60

1.1

iu/ml

7350.7

9551.9

0.07

254

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.60

0.0

3.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

137

0.63

0.60

1.2

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.59

0.0

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

387

0.80

0.59

1.2

g/l

40.5

39.9

0.08

205

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

118

1.39

0.59

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

118

1.39

0.59

1.9

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

194

1.30

0.59

1.0

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

566

0.84

0.59

1.0

u/ml

4.7

2.6

0.61

209

(43055442) Apixaban [Mass/volume] in Serum or Plasma

177

1.31

0.59

1.6

ug/l

86.0

118.6

1.27

150

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1271

12686

0.97

0.59

4.3

4.9

32.9

0.04

815

8416

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

111

1204

0.89

0.58

1.1

1.2

miu/ml

171.7

209.8

0.50

475

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.44

0.58

1.0

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

914

8509

1.04

0.58

1.5

1.7

1.5

1.6

0.09

780

7215

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.71

0.57

1.3

1.4

—

(3024471) HLA-A [Type]

212

0.73

0.57

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

374

0.80

0.57

1.4

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

740

0.86

0.56

1.1

1.2

titre

90.0

161.1

—

135

(3016038) Potassium [Moles/volume] in Urine

684

1.15

0.56

1.3

1.1

mmol/l

36.9

33.7

0.64

566

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

230

1.26

0.56

2.4

2.7

mmol/l

7.7

7.8

0.05

144

(4146454)

148

1298

1.10

0.56

2.7

—

(3032057) Clostridioides difficile [Presence] in Stool

239

1.25

0.56

1.8

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

687

0.86

0.55

1.0

u/ml

4.6

1.9

0.43

143

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

210

0.74

0.55

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

533

1.16

0.54

1.2

—

(3011985) Renin [Units/volume] in Plasma

140

1227

1.10

0.54

1.3

mu/l

85.6

61.1

0.43

122

1089

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.48

0.53

3.9

2.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

209

0.74

0.53

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

121

1297

0.90

0.53

1.4

1.6

g/l

0.9

0.09

968

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

142

0.68

0.53

1.4

1.2

—

(44806071)

0.60

0.51

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.60

0.51

1.2

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

527

1.16

0.51

1.3

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

105

1.38

0.51

8.2

5.1

ug/min

57.7

44.3

0.41

(3034891) Synovial lining cells/100 cells in Synovial fluid

515

0.84

0.51

1.5

1.7

4.0

1.23

118

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

298

2706

1.07

0.51

2.5

1.5

g/l

0.0

0.00

270

2469

(4062490)

833

0.88

0.49

1.2

1.4

—

(40768443) Skin Pathology biopsy report

406

3729

1.05

0.48

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

194

0.75

0.48

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

132

1164

1.10

0.47

1.2

1.3

pmol/l

349.4

266.1

0.39

103

874

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

450

1.16

0.47

1.4

1.3

nmol/l

0.3

0.2

0.27

334

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

450

1.16

0.47

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

120

1054

1.10

0.47

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

130

1147

1.10

0.46

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

246

0.79

0.46

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.60

0.45

1.2

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.60

0.45

1.0

—

3.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

181

0.75

0.45

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

320

0.82

0.45

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

341

0.82

0.45

2.6

2.8

umol/l

31.3

28.9

0.68

252

(40768446) Kidney Pathology biopsy report

291

1.20

0.45

1.5

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

195

1.24

0.43

1.0

1.1

89.3

87.4

0.07

102

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

123

0.71

0.43

1.1

1.4

71.4

71.7

—

115

(3016330) Potassium [Moles/time] in 24 hour Urine

127

0.69

0.43

1.1

1.3

—

92.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.43

0.42

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

401

1.16

0.42

1.6

1.5

umol/l

18.9

9.9

0.61

281

(3001729) Color of Synovial fluid

0.66

0.42

1.0

1.7

—

(3004775) Volume in Urine collected for unspecified duration

106

932

1.10

0.42

2.3

736.4

659.6

0.81

632

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

101

1.34

0.42

1.5

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

189

0.77

0.42

1.2

1.6

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.8

—

124.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.51

0.41

1.2

1.4

1.5

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

1431.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

5.8

—

0.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.36

0.41

3.3

2.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

642

5993

1.04

0.40

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

220

0.79

0.40

1.1

—

(3020650) Glucose [Presence] in Urine

206

1.22

0.40

1.3

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

294

0.82

0.40

1.1

—

(4133840)

215

1.21

0.40

1.3

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

198

0.78

0.39

1.3

1.7

mmol/l

1.2

0.17

191

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

144

0.74

0.39

1.1

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

128

1.28

0.39

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

847

0.90

0.39

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

520

0.87

0.38

1.1

nmol/l

2.3

6.2

1.00

112

(3029075) Extractable nuclear Ab panel - Serum

218

0.80

0.38

1.0

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

835

0.90

0.38

1.2

1.4

g/l

6.8

6.9

0.10

576

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.37

1.1

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

834

0.90

0.37

1.2

1.4

g/l

0.4

0.13

578

(3028192) IgG subclass 2 [Mass/volume] in Serum

834

0.90

0.37

1.2

1.4

g/l

2.8

3.0

0.57

574

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

122

0.71

0.35

1.1

1.4

mu/l

3749.1

676.7

—

114

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

282

1.17

0.34

4.9

7.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

878

0.91

0.33

1.3

nmol/l

1.4

0.24

795

(3034092) Cytoplasmic Ig cells/100 cells in Blood

114

1.27

0.33

15.4

9.6

—

(3044927) Protein electrophoresis panel - Urine

137

1236

1.07

0.33

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

173

1777

0.94

0.33

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

123

1.26

0.33

1.3

1.6

—

(3025130) Human papilloma virus identified in Specimen

596

1.10

0.32

1.4

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

204

1.19

0.31

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.33

0.31

1.3

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

302

2798

1.04

0.31

1.5

1.4

iu/ml

12.5

16.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

284

0.85

0.30

1.1

1.0

u/ml

3.8

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

151

1.22

0.30

1.0

1.1

—

(44806420)

368

1.13

0.30

2.2

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

223

1.17

0.30

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

126

0.77

0.29

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

296

1.14

0.29

1.7

1.4

pmol/l

14.0

16.6

2.32

241

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

120

1085

1.07

0.29

1.2

u/ml

272.1

292.6

0.32

702

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

226

2287

0.95

0.27

1.8

1.9

mg/l

11.3

0.00

208

2104

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

116

0.75

0.27

1.3

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

1.26

0.27

3.2

4.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

290

0.87

0.26

1.1

miu/ml

1561.9

1639.6

0.12

290

(3009445) Proteinase 3 Ab [Units/volume] in Serum

439

4376

0.97

0.26

1.5

u/ml

16.1

16.9

0.03

(3015183) Erythrocyte sedimentation rate

263

1.14

0.26

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

438

1.10

0.25

1.2

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

227

1.15

0.25

1.1

1.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

146

1.19

0.25

2.5

1.2

111.4

107.7

0.16

139

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.18

0.24

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.18

0.24

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.18

0.24

1.4

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

267

0.87

0.24

1.2

nmol/l

89.3

145.0

2.64

185

(3001186) Copper [Moles/volume] in Serum or Plasma

174

1.17

0.23

1.1

1.2

umol/l

17.5

16.3

1.06

160

(3014599) Egg white IgE Ab [Units/volume] in Serum

266

0.87

0.23

1.1

1.0

u/ml

1.3

0.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

286

0.88

0.23

1.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

283

2832

0.97

0.22

2.6

2.3

ug/min

127.6

113.5

0.18

160

1649

(3023419) Bacteria identified in Sputum by Culture

140

1287

1.05

0.22

2.6

2.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

131

0.81

0.22

1.1

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

1.22

0.22

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

101

921

1.06

0.21

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.0

—

312.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

8.1

—

73.5

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

135.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

134

1361

0.95

0.21

1.7

1.8

mu/l

265.0

300.5

1.00

125

1252

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

100

0.77

0.21

1.9

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

294

0.89

0.21

1.3

1.1

g/l

—

0.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.20

0.0

1.3

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.20

0.0

1.0

—

134.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

511

1.08

0.20

3.7

3.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.18

0.19

1.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

831

1.06

0.19

1.2

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

114

1.19

0.19

4.3

2.5

—

34.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

114

1.19

0.19

1.9

1.7

umol/l

52.1

46.0

0.36

114

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

484

1.08

0.19

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

133

1.16

0.18

1.1

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

799

0.94

0.18

1.2

u/ml

42.5

47.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

580

1.07

0.17

2.5

2.0

umol/l

22.0

16.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.22

0.17

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

227

2265

0.97

0.17

3.7

3.6

mg/l

31.9

27.1

1.03

140

1490

(4024509)

112

1034

1.05

0.17

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.73

0.17

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

299

0.91

0.17

1.3

30.0

32.4

0.15

194

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

107

1.17

0.16

2.3

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.12

0.16

1.0

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

207

0.89

0.15

1.1

1.0

u/ml

0.1

2.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.77

0.15

1.2

1.1

—

(3025315) Body weight

0.76

0.15

6.3

5.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

386

1.08

0.15

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.15

0.15

1.0

—

(3023410) Appearance of Cerebral spinal fluid

764

0.95

0.15

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.10

0.15

1.6

1.5

—

(3017704) Immunofixation for Urine

557

1.06

0.14

1.4

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

201

1.11

0.14

1.0

1.1

82.4

86.0

—

101

(3027923) C peptide [Moles/volume] in Serum or Plasma

563

0.94

0.13

1.3

nmol/l

1.2

0.13

420

(3001686) Cold agglutinin [Titer] in Serum or Plasma

174

1.11

0.13

1.9

1.3

titre

184.4

229.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

324

0.92

0.13

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

204

0.90

0.13

4.3

7.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

107

0.81

0.13

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

263

0.92

0.12

1.6

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

129

1.12

0.11

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

222

0.91

0.11

1.0

1.3

mg/l

1.4

47.9

0.98

174

(3033923) Metanephrine [Moles/time] in 24 hour Urine

202

0.91

0.11

1.2

1.1

umol/24h

0.6

0.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

440

1.06

0.11

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

242

1.08

0.10

4.7

7.5

—

(3006653) Thiamine [Moles/volume] in Blood

431

1.05

0.10

1.0

1.1

nmol/l

132.9

137.8

0.22

431

(3011335) Digoxin [Mass/volume] in Serum or Plasma

121

1.12

0.10

2.1

2.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

708

1.04

0.09

1.1

1.3

promille

1.0

1.3

1.22

532

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.05

0.09

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

132

1244

1.03

0.09

1.2

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

130

0.89

0.09

10.9

11.9

mmol/l

6.9

5.5

0.60

130

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

910

8873

0.99

0.09

1.3

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

131

1.11

0.09

1.3

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

1.13

0.09

1.1

1.0

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

338

0.94

0.09

1.9

2.0

ug/l

62.9

52.8

0.69

329

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

510

1.04

0.08

2.5

2.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.79

0.08

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

226

1.07

0.08

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.78

0.08

1.2

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.04

0.08

1.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

218

0.93

0.07

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

650

0.97

0.07

1.3

1.2

mmol/l

11.9

11.8

0.03

186

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.09

0.07

1.1

u/l

9.5

12.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

207

1969

1.02

0.07

1.3

1.5

nmol/l

0.9

0.8

1.47

176

1613

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.02

0.07

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.12

0.07

1.5

2.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.87

0.06

1.4

1.1

umol/24h

1.5

1.7

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.89

0.06

1.1

mg/g

7.0

8.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

373

3644

0.99

0.06

1.7

1.8

u/l

39.0

38.7

0.09

326

3109

(3034426) Prothrombin time (PT)

255

0.95

0.06

1.2

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

315

1.04

0.05

6.6

5.7

65.7

70.7

0.48

263

(3037692) Legionella sp identified in Specimen by Organism specific culture

258

1.05

0.05

1.1

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

163

1.07

0.05

2.3

1.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

154

1.07

0.05

1.1

1.0

u/ml

0.9

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

221

1.05

0.04

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

413

1.03

0.04

1.1

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

606

1.02

0.03

14.4

11.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

203

0.95

0.03

1.5

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

165

1.05

0.03

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

310

0.97

0.03

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

183

0.95

0.03

1.5

1.1

—

(3003129) Base excess in Capillary blood by calculation

290

1.03

0.03

1.6

mmol/l

-0.3

0.5

0.69

275

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

251

0.96

0.03

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

202

0.96

0.03

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

202

0.96

0.03

1.4

1.8

mmol/l

1.2

0.12

195

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

493

1.02

0.02

1.3

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

128

1.06

0.02

1.1

1.4

—

7.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

376

0.98

0.02

1.7

1.8

umol/l

98.3

115.4

0.32

198

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

474

4599

1.00

0.02

2.9

3.0

pmol/l

4.3

4.4

2.33

418

3997

(3043238) Trisomy 21 risk [Likelihood] in Fetus

210

0.97

0.01

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

167

1624

0.99

0.01

1.2

u/l

69.2

26.4

1.20

144

1387

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

371

1.02

0.00

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

355

3425

1.00

0.00

1.5

1.6

titre

280.0

284.6

0.01

174

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

112

0.95

0.00

1.4

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

110

0.97

0.00

1.6

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

218

1.02

0.00

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

247

0.98

0.00

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

247

0.98

0.00

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

238

1.02

0.00

1.3

—

(4198724)

168

0.98

0.00

1.5

1.4

—

(40757373) Influenza virus identified in Isolate

199

1.02

0.00

1.3

1.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

170

1.02

0.00

1.0

1.2

—

405.0

—

(3028433) Virus identified in Specimen by Culture

268

1.01

0.00

1.2

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

246

0.98

0.00

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

246

0.98

0.00

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.02

0.00

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

161

1.02

0.00

1.1

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

308

1.00

0.00

28.1

25.5

ug/l

104.0

111.8

0.41

250

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

203

1.00

0.00

1.9

2.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

305

1.01

0.00

1.2

1.5

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

152.3

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.98

0.00

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.96

0.00

1.3

1.1

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.90

0.00

1.4

1.2

nmol/l

23.4

24.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.99

0.00

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.85

0.00

1.2

1.9

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.4

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

9.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.01

0.00

1.2

1.1

ng/l

757.8

1417.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.90

0.00

1.4

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.95

0.00

1.4

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.97

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_COLORECTAL_EXALLC – Colorectal cancer, excluding all cancers (controls excluding all cancers)

GWS hits: 26

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Colorectal cancer, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints